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The progression of early hematopoietic differentiation remains a topic of 
controversy.  Topics of ongoing debate include the identification of a pure hematopoietic 
stem cell population and bifurcation of the lymphoid and myeloid lineages following 
commitment by multipotent progenitors.  This dissertation contributes to the current 
knowledge of early hematopoietic differentiation and enhances the understanding of 
hematopoietic stem cell and progenitor biology by characterizing CD62L as a novel 
marker of early hematopoietic differentiation.  Transplant studies revealed in vivo 
evidence for the existence of stem cell-containing CD62L– fraction and multipotent 
progenitor-containing CD62L+ fraction within the traditionally defined hematopoietic 
stem cell population.  Sca-1 fractionation of the hematopoietic stem cell compartment 
demonstrated that cells of the Sca-1HIGH subset were almost homogeneous in their lack of 
CD62L expression.  In contrast, the Sca-1LOW subset contained a heterogeneous mixture 
of CD62L+ and CD62L– cells.  Engraftment analysis of the Sca-1LOW and Sca-1HIGH 
fractions demonstrated that the CD62L– cells of both Sca-1 fractions contained 
hematopoietic stem cells, with a higher frequency of stem cells within the Sca-1HIGH 
CD62L– fraction.  Within the traditionally defined multipotent progenitor population, 
CD62L segregated a CD62L+ lymphoid-biased multipotent progenitor and a CD62L– 
multipotent progenitor with robust multipotency.  Flow cytometric analysis of CD62L 
expression pattern within the multipotent progenitor population demonstrated that 
CD62L-based separation of progenitors was achieved independently of Flt3 expression.  
Lastly, the concomitant expression of CD62L and Flt3 revealed a rare population of 
 v
multipotent progenitors and a possible B cell/erythroid bipotent precursor within the 
previously demonstrated myeloid compartment.  Simultaneous loss of CD62L and Flt3 
was observed in the myeloid lineage-specific population.  Together, these data 
demonstrate the expression of CD62L within the context of early hematopoietic 
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…there comes a point where you’ll find something out, 
where you’ll see something, 
or where something will suddenly come together, 
and you’ll realize that you know something that  
no one else in the world knows yet. 
Just you. 
No one else. 
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Hematopoietic stem cells 
 The source of all blood cells in the body is the hematopoietic stem cell (HSC).  
Residing primarily in the bone marrow throughout the entire life of the animal, HSC 
amazingly replenish the blood supply by generating billions of cells while maintaining 
the stem cell pool (reviewed in Ogawa, 1993).  The various functions of mature progenies 
of HSC are essential for preservation of the life of the animal and are specific to the 
specialized progenies.  The progenies and some of their specialized functions are: red 
blood cells (RBC) serve as transports of oxygen throughout the body, platelets induce 
blood clotting in the event of an injury, and white blood cells (WBC; lymphocytes, 
granulocytes and macrophages) function as protectors against pathogens (reviewed in 
Sigvardsson, 2009).  These facts demonstrate the importance of HSC and target HSC as a 
subject of intense research. 
 The first experimental demonstration of HSC function was published in 1951 
when a transplant experiment demonstrated that bone marrow cells could rescue 
irradiated mice and guinea-pigs (Lorenz et al., 1951).  In the 1960s, several studies 
demonstrated that a population of bone marrow cells was capable of generating RBC in 
the spleen, and upon transplantation into lethally irradiated hosts, provided 
radioprotection (Till and McCulloch, 1961; Becker et al., 1963; Wu et al., 1968).  With 
the advent of fluorescence activated cell sorter technology, several groups were able to 
successfully concentrate bone marrow fractions containing HSC (Visser et al., 1984; 
Muller-Sieburg et al., 1986).  However, it was not until 1988 that a highly enriched 
population of HSC was identified through targeting a subset of bone marrow cells using 
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the surface expression pattern of Lin–Sca-1+Thy1.1LOW for FACS sorting (Spangrude et 
al., 1988).   
Since then, an array of new markers has been identified in an attempt to isolate 
the purest HSC population possible.  A currently widely used marker is C-kit, which has 
been demonstrated to enrich HSC in the brightest fraction of C-kit-labeled bone marrow 
cells (C-kitBRIGHT) and has become part of a regular protocol for isolating HSC (Besmer, 
1991; Ikuta and Weissman, 1992; Morrison et al., 1997; Rawls et al., 2001).  Gene 
expression studies have identified three members of the SLAM (Signaling Lymphocytic 
Activation Molecules family surface receptor molecules) for isolating HSC (CD150+, 
CD48–, CD244–; Kiel et al., 2005; Papathanasiou, 2009).  Another widely used marker 
for HSC purification is CD34, a ligand for CD62L.  While human HSC express CD34, 
experiments in mouse models have demonstrated that HSC reside in the CD34– fraction. 
(Osawa et al., 1996; Yang et al., 2005).  The DNA-binding supravital dye Hoechst 33342 
has been demonstrated to be efficiently effluxed by a bone marrow population (side 
population or SP) that has been identified to be enriched for HSC (Goodell et al., 1996).  
Labeling the bone marrow with the vital mitochondrial dye rhodamine-123 has also 
resolved a side population that contains HSC (Spangrude and Johnson, 1990; Okada et al., 
1993; Li and Johnson, 1995).  Despite the availability of abundant markers for HSC 
isolation, no group has made the claim of isolating an absolutely pure HSC population, 
indicating that a comprehensive marker set for HSC isolation is not yet complete. 
The estimation for the frequency of HSC in the whole bone marrow is quite broad.  
Currently it is estimated that 1 in 104 to 1 in 105 cells in the bone marrow represent the 
HSC frequency (Chao et al., 2008; Luc et al., 2008; Orkin and Zon, 2008).  An accurate 
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calculation of HSC in vivo has proven to a challenge.  When a population of cells, 
containing an unknown number of HSC, is transplanted into lethally irradiated hosts, it is 
unclear what fraction of transplanted HSC contributes to the reconstitution of the 
hematopoietic system.  Furthermore, it is also unclear if contributing HSC generate equal 
number of progenies.  A common way to characterize the degree of hematopoietic 
reconstitution is the calculation of repopulating units (RU; Harrison, 1980).  
Transplanting a population of cells containing an unknown number of HSC into lethally 
irradiated hosts along with competitor whole bone marrow cells establishes an internal 
standard (100K competitors = 1 RU) to compare the repopulation capacity of the 
population in question (Harrison et al., 2005; Yuan et al., 2005).  Several constraints limit 
this method, such as the number of recipients used, number of donor cells transplanted, 
and the engraftment duration of donor cells (Purton and Scadden, 2007).  While the RU 
calculation does not determine the absolute number of HSC in a given population, it is 
useful for calculating a relative number of HSC among different populations.  In vitro 
approaches to the determination of HSC frequency suffer from the fact that the observed 
multipotency output does not necessarily represent HSC as multipotent progenitors also 
exhibit significant output of progenies into all lineages, and the long term persistence 
observed in vitro may be an unintended artifact.  Regardless, an in vitro based estimation 
has been made at 2.8 ± 1.06 HSC per 105 bone marrow cells (Sieburg et al., 2002).  
Taken together, a conservative estimation of HSC frequency appears to be approximately 
1 HSC per 105 whole bone marrow cells. 
The key to isolating the absolutely pure HSC and calculating an accurate HSC 
frequency is to identify the appropriate set of markers.  Knowing the actual HSC markers 
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will assure the isolation of pure, live HSC, and facilitate future studies seeking greater 
understanding of stem cell biology. 
 
Early hematopoietic differentiation 
 The traditional model of hematopoiesis identifies the hematopoietic stem cell 
compartment of the bone marrow as the site of early hematopoietic differentiation.  The 
hematopoietic stem cell compartment is identified by a shared expression pattern of stem 
cell-associated surface markers, Sca-1 and C-kit (Spangrude et al., 1988; Ikuta and 
Weissman, 1992).  These cells also lack an array of mature cell surface markers 
collectively known as lineage (Lin).  Therefore, the hematopoietic stem cell compartment 
is also commonly referred to as KLS for C-kit+Lin–Sca-1+.  Within the KLS population, 
three early hematopoietic populations have been identified according to Flt3 and Thy1.1 
expression levels: Thy1.1+ Flt3– long-term HSC (LT-HSC), Thy1.1+ Flt3+ short-term 
HSC (ST-HSC), and Thy1.1– Flt3+ multipotent progenitors (MPP) (Spangrude et al., 
1988; Morrison et al., 1997; Adolfsson et al., 2001; Christensen and Weissman, 2001).  
LT-HSC is the true HSC, and represents the origin of hematopoietic differentiation.  As 
LT-HSC enters the differentiation state, its capacity for self-renewal becomes limited and 
is accompanied by the expression of Flt3.  While LT-HSC can self-renew for the life of 
the animal, ST-HSC can persist for only 6-12 weeks (Morrison and Weissman, 1994; 
Christensen and Weissman, 2001).  Further maturation is characterized by the loss of 
self-renewal capacity and Thy1.1 expression.  Multipotency is still preserved, therefore, 
the cells of this stage are known as MPP.  These cells represent the end subpopulation 
within the KLS population.  Outside KLS, the progenitors are bifurcated into lymphoid 
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and myeloid lineage committed progenitors through the establishment of common 
lymphoid progenitors (CLP) (Kondo et al., 1997) and common myeloid progenitors 
(CMP) (Akashi et al., 2000).   
 This traditional model of early hematopoietic differentiation has been the subject 
of much controversy.  Adolffson et al. have demonstrated that the top 25% of KLS cells 
for Flt3 expression rapidly lost the potential to generate platelets and RBC (Meg/E 
potential) and that this population was mostly lymphoid-biased. Based on these 
observations, they proposed a new name for this population, LMPP for lymphoid-primed 
multipotent progenitors (Adolfsson et al., 2005).  The laboratory responsible for the 
establishment of the traditional hematopoietic tree, the Weissman group at Stanford 
University, released a rebuttal study demonstrating that there is a detectable amount of 
Meg/E activity from the newly proposed LMPP population, however, they conceded that 
the Meg/E activity was reduced compared to the Meg/E activity expected from the MPP 
population (Forsberg et al., 2006).  These studies demonstrate that the MPP population of 
KLS is not a homogeneous population.  Another example of heterogeneity within MPP 
came from the Kondo laboratory.  They have demonstrated that by using the vascular cell 
adhesion molecule-1 (VCAM-1), it was possible to subfractionate the MPP population 
into a VCAM-1– LMPP-like population and a VCAM-1+ traditional MPP (Lai et al., 
2005; Lai and Kondo, 2006).  Interestingly the cells of VCAM-1– LMPP were mostly 
Flt3HIGH cells; however, VCAM-1+ MPP contained both low and high levels of Flt3.  
This observation suggests that perhaps the VCAM-1+ MPP is also heterogeneous. 
 Together, the above findings represent ongoing research efforts to complete the 
identification of all members of the hematopoietic tree.  One of the ways that will 
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expedite this process is to identify novel markers that will aid in the identification of 
subsets that are currently unknown. 
 
CD62L and hematopoietic differentiation 
 CD62L (also known as L-Selectin) is a member of the Selectin family of cell 
surface adhesion molecules that is constitutively expressed on many WBC (Griffin et al., 
1990; Tedder et al., 1990).  Three glycoprotein ligands for CD62L have been reported: 
GlyCam-1 (Laskey et al., 1992), CD34 (Baumhueter et al., 1993), and MAdCAM-1 
(Briskin et al., 1993).  Two isoforms of CD62L have been described to be expressed due 
to posttranslational modifications: a 74 kDa-sized isoform on lymphocytes and a 100 
kDa-sized isoform on neutrophils (Lewinsohn et al., 1987).  Unlike the other two 
members of the Selectin family, E-selectin and P-selectin, CD62L contains an 
extracellular cleavage site near the plasma membrane (Ivetic and Ridley, 2004).  
Following an activation stimulus, the extracellular domain of CD62L is autoproteolysed 
and releases soluble fragments of CD62L, 62 kDa-sized fragments from lymphocytes and 
75-100 kDa-sized fragments from neutrophils (Schleiffenbaum et al., 1992). 
CD62L has been described to play an important role in lymphocyte migration into 
peripheral lymph nodes and sites of inflammation (Arbones et al., 1994).  It has also been 
suggested that the loss of CD62L might be required for CD62L+ cells to migrate across 
endothelium (Kishimoto et al., 1989).  Knockout experiments in mice have demonstrated 
that the complete loss of CD62L resulted in impaired lymphocyte migration to peripheral 
lymph nodes, impaired neutrophil migration to peritoneum and defects in leukocyte 
rolling (Arbones et al., 1994).  While intracellular signaling induced by CD62L has not 
 8
been well characterized, in vitro stimulation of CD62L, using monoclonal antibodies 
against Jurkat cells, has resulted in the induction of p56lck, Grb2/Sos, Ras, and Rac2 to 
peroxide anion production signaling cascade (Brenner et al., 1996).  Interestingly, a 
measurable amount of CD62L suppression has also been observed in the blood serum 
samples of human patients with hereditary hemochromatosis (Norris et al., 2010).   
Characterization of CD62L in the context of hematopoietic differentiation has 
been limited.  One of the ligands for CD62L listed above is CD34, a marker of HSC 
(Baumhueter et al., 1993; Osawa et al., 1996; Yang et al., 2005).  However, the 
relationship between CD62L and HSC has not been ascertained. 
Previously our laboratory has reported the subfractionation of the Thy1.1– 
fraction of KLS (KLST–) using CD62L (Perry et al., 2004).  It was reported that the 
majority of KLST– cells expressed CD62L.  When the CD62L– fraction of KLST– were 
transplanted into lethally irradiated recipients, the donor cells generated significant 
engraftment in B cell, T cell, granulocyte and monocyte lineages, indicative of an MPP 
population.  Interestingly, when the CD62L+ fraction of KLST– were transplanted, the 
donor cells generated robust T cell activity with lesser amounts of B cell, granulocytes 
and monocytes.  These findings indicated that CD62L expression marked a bone marrow 
population similar to an early T-lineage progenitor (ETP; Allman et al., 2003).  These 
observations led our laboratory to suspect a greater capacity of CD62L to identify stages 





Transplant experiment design 
The primary tool used in this dissertation was bone marrow transplantation for in 
vivo analysis of target cells.  The general schematic for the experimental procedure is 
shown in Figure 1.1.  Four strains of mice were used.  For donor mice, green fluorescent 
protein (GFP) transgenic mice derived by microinjection of C57B/6 oocytes were used.  
These mice were kindly provided by Dr. Masaru Okabe (Osaka University, Osaka, Japan) 
(Spangrude et al., 2006).  These mice express GFP in all blood lineages except the RBC 
lineage.  They also express the Thy1.2 allele.  This is problematic for the study of KLS 
cells, since only the Thy1.1 allele marks HSC (Spangrude and Brooks, 1992).  Therefore, 
these mice were bred with GFP– Thy1.1+ mice that were bred in our laboratory to 
produce GFP+Thy1.1+ litters. 
When transplanted into GFP– recipient mice, GFP+ donor cells generate GFP+ 
progenies that can be tracked using flow cytometry.  However, the lack of GFP 
expression in the erythroid lineage prevents the tracking of RBC generation.  Therefore, 
we have developed a novel HPLC protocol to discriminate the donor-derived RBC from 
the recipient RBC using allelic variants of hemoglobin beta chain (Hbb).  The 
GFP+Thy1.1+ mice used in our experiments express the HbbS variant, while the GFP–
Thy1.2+ mice express the HbbD variant.  This system is explained in greater detail in 
Appendix A. 
Whole bone marrow cells were harvested from the GFP+Thy1.1+HbbS mice.  The 
cells were incubated with a cocktail of rat antibodies directed against mature cell surface 
markers (Lin: B220, CD2, CD3, CD5, CD8, CD19, Ly-6G, Mac1 and Ter119).  The 
labeled mature cells were incubated secondarily with anti-rat antibodies coupled with 
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magnetic beads.  Finally the labeled mature cells were removed using a magnetic column.  
When the Lin-depleted cells were obtained, they were stained for fluorochrome-
conjugated antibodies to FACS purify specific populations.  Following a successful 
FACS sort, the purified target cells were retro-orbitally injected into lethally irradiated 
GFP–Thy1.2+HbbD mice (12~13 Gy). 
Following the transplantation, periodically the peripheral blood samples were 
drawn retro-orbitally using heparinized capillary tubes.  The blood samples were counted, 
processed for flow cytometry analysis for the detection of WBC and platelet engraftment, 
or HPLC analysis for RBC engraftment through HbbS versus HbbD quantification.  
 
Scope of the study 
 Flow cytometric analysis of CD62L expression has revealed heterogeneity among 
the previously defined LT-HSC, ST-HSC and MPP populations.  Using transplant studies, 
the work described in this dissertation characterized the constituents of KLS at a greater 
resolution.  The techniques used here allow for the identification and quantification of the 
engraftment potential of transplanted cells in all lineages.  The data represent 
examination of lineage potential among various subpopulations identified through 
CD62L expression pattern and provides opportunities for refining the traditionally 
defined hematopoietic tree.  While the findings are based on differential CD62L 
expression patterns among early hematopoietic cells, they do not indicate any direct 
relationship between CD62L and HSC/progenitor function.  The application of CD62L as 
presented justifies the use of CD62L for identifying subpopulations that were not possible 
previously.  The engraftment data of CD62L subfractionated populations provide in vivo 
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evidence for gradual change in lineage potential, in contrast to the widely described 
stage-by-stage developmental model with abrupt lineage commitments.  The transplant 
studies using competitor whole bone marrow cells in the context of lethally irradiated 
recipients allowed for the RU calculation to determine the relevant population for HSC 
enrichment and created future opportunities for such analysis in other compartments of 
early hematopoietic progenitors. 
 
Significance 
 One of the primary goals of studying hematopoiesis is to clearly identify the 
hematopoietic tree that accurately portrays the developmental events occurring in vivo.  
The initially established model of LT-HSC→ ST-HSC → MPP→ CLP or CMP 
(Morrison et al., 1997; Kondo et al., 1997; Akashi et al., 2000; Adolfsson et al., 2001; 
Christensen and Weissman, 2001) has been proven to be oversimplified and inaccurate 
(Adolfsson et al., 2005; Forsberg et al., 2006).  Ongoing studies searching for more 
markers and missing populations in the hematopoietic tree indicates that more data is 
required to completely understand the developmental events of hematopoiesis.  The data 
presented in this dissertation contributes to that effort.  Using antibodies against CD62L, 
we demonstrate heterogeneity within the early populations of hematopoiesis.  In vivo 
evidence points to CD62L as a potential substitute for currently used markers for efficient 
HSC enrichment as well as its concomitant use with the other markers to isolate purer 
HSC population.   
In addition, the data support the idea that lineage commitment occurs gradually, 
accompanied by the gradual changes in the expression patterns of surface markers.  
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Currently, it is widely perceived that the progression of hematopoietic development 
occurs in a stage-by-stage manner with instant changes in the expression profiles of 
surface markers.  While some surface markers’ expressions may change quickly and 
lineage potential lost abruptly with such changes, we and others have observed that there 
are other markers that behave differently.  Therefore, it is important that more evidence 
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The source of adult hematopoiesis is a population of hematopoietic stem cells 
(HSC) that replenishes itself and generates the entire blood system throughout the life of 
the animal.  While a set of known markers for identifying a population containing HSC 
has been defined, a pure population of HSC has been unobtainable.  In this report we 
present an additional marker previously not reported for an effective enrichment of HSC.  
We observed that in vivo transplant studies using CD62L to fractionate the hematopoietic 
stem cell compartment led to a multipotent progenitor-enriched CD62L+ fraction and a 
HSC-enriched CD62L– fraction.  We also observed that the use of CD62L in addition to 
Flt3, a commonly used marker for HSC-enrichment, uncovered a CD62L–Flt3– 
population that is the primary source of HSC.  These data provide direct evidence for the 
application of CD62L in combination with other markers for isolating a more highly 
enriched population of HSC.  Furthermore, the data establish CD62L as an effective 




 In adult mammals, all blood cells originate from a pool of hematopoietic stem 
cells (HSC) residing in the bone marrow.  These adult stem cells possess the prototypical 
stem cell characteristics: the ability to self-renew through mitosis and the capacity to 
generate cells of all hematopoietic lineages (reviewed in Weissman, 2000).  As HSC 
mature and differentiate into progeny cells, their self-renewal ability becomes limited and 
their multipotency lost through lineage commitment.  The early events of hematopoietic 
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differentiation have been described to occur within a subset of immature cells in the bone 
marrow identified by a shared expression pattern of surface markers: co-expression of 
stem cell-associated markers C-kit and Sca-1 and the lack mature cell markers 
collectively known as Lineage (Lin) (Spangrude et al, 1988; Ikuta and Weissman, 1992).  
This subset of hematopoietic progenitors have been named the hematopoietic stem cell 
compartment or KLS (C-kit+Lin–Sca-1+). 
 Within the KLS population reside three distinct subpopulations that delineate the 
early hematopoietic differentiation events.  According to expression patterns of Flt3 and 
Thy1.1 surface markers, the three subpopulations are designated as Thy1.1+ Flt3– long-
term HSC (LT-HSC), Thy1.1+ Flt3+ short-term HSC (ST-HSC), and Thy1.1– Flt3+ MPP 
(Spangrude et al., 1988; Morrison et al., 1997; Adolfsson et al., 2001; Christensen and 
Weissman, 2001).  The labels reflect each subpopulation’s hematopoietic potential.  LT-
HSC contains the true HSC that initiates hematopoiesis.  As LT-HSC enters 
differentiation, it upregulates Flt3 and is labeled ST-HSC, due to its limited capacity for 
self-renewal.  ST-HSC when transplanted has been shown to reconstitute the 
hematopoietic system of recipients for approximately 6~12 weeks, and therefore, is not a 
true HSC (Morrison and Weissman, 1994; Christensen and Weissman, 2001).  Finally, 
the last stage within the KLS population is the MPP stage that has lost self-renewal 
capability, accompanied by the loss of Thy1.1, but maintains multipotency.  The 
heterogeneity within this subpopulation has been the focus of recent discussions (Chapter 
3; Adolfsson et al., 2005; Akashi et al., 2005; Lai et al., 2005; Lai and Kondo, 2006; 
Forsberg et al., 2006). 
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 As the source of hematopoiesis, the isolation of pure HSC has been the target of 
much research.  A major breakthrough in HSC purification came in 1988 when 
Spangrude et al. demonstrated that a highly enriched HSC population can be obtained 
through the application of fluorescence-activated cell sorter (FACS) using the surface 
expression pattern of Lin–Sca-1+Thy1.1LOW (Spangrude et al., 1998).  Subsequent 
studies have added an extensive array of markers in order to obtain the purest HSC 
sample possible.  C-kit, a receptor for stem cell factor, has been identified as a significant 
marker that contains the HSC in its C-kitBRIGHT fraction (C-kit+ hereafter) and is 
currently a part of regular regimen for HSC and progenitor isolation studies (Besmer, 
1991; Ikuta and Weissman, 1992; Morrison et al., 1997; Rawls et al., 2001).  Gene 
expression studies have identified a set of surface receptors of the SLAM family 
(Signaling Lymphocytic Activation Molecules) for isolating HSC (Kiel et al., 2005).  
Another widely used marker for HSC purification is CD34, a ligand for CD62L (Osawa 
et al., 1996; Yang et al., 2005). 
 Previously our laboratory has reported that the CD62L adhesion molecule can be 
used to fractionate the Thy1.1– portion of KLS to identify a T cell-biased CD62L+ MPP 
and a CD62L– MPP with more generally distributed multipotency (Perry et al., 2004).  
These findings have led us to hypothesize that CD62L is an early marker of 
hematopoietic development.  To test this hypothesis, we have examined in vivo 
engraftment potential of CD62L– and CD62L+ fractions of KLS through transplant 
experiments.   
 In this report we establish CD62L as a novel marker for HSC purification.  Our 
data demonstrate that in a transplant setting, the CD62L– fraction of KLS contains highly 
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enriched HSC, while the CD62L+ fraction contains MPP with a limited duration of 
output.  Furthermore, we present that the CD62L– fraction contains HSC in both Sca-
1HIGH as well as Sca-1LOW fractions of KLS, albeit less HSC in Sca-1LOW, indicating a 
gradual population shift as Sca-1 is downregulated.  Lastly we present evidence that the 
primary source of HSC resides in the CD62L– fraction of the now widely accepted Flt3–
Thy1.1LOW HSC population.  These data indicate that CD62L is an effective marker for 
isolating an enriched population of HSC. 
 
Results 
CD62L expression pattern in KLS is  
analogous to Flt3 expression pattern 
 
In order to test the hypothesis that CD62L is a marker of early hematopoietic 
differentiation, KLS, the pool of early hematopoietic progenitors, was analyzed for 
CD62L expression along with Thy1.1 (Figure 2.1A).  The expression pattern revealed a 
distribution of CD62L expression between the Thy1.1– to Thy1.1LOW (Thy1.1+ hereafter) 
populations.  Visual examination of the data indicated a clear discrimination of three 
distinct populations: CD62L–Thy1.1+, CD62L+Thy1.1+, and CD62L+Thy1.1–.  The 
three population pattern is analogous to the traditionally defined LT-HSC, ST-HSC and 
MPP indicted by Flt3 and Thy1.1 levels (Figure 2.1B).  The frequency of cells belonging 
to each distinct population in figure 2.1A is similar to the frequency of cells belonging to 
each population in Figure 2.1B.  Moreover, co-staining of CD62L and Flt3 in KLS 
revealed a high degree of co-expression, while a significant number of cells were 
mutually exclusive for CD62L or Flt3 expression (data not shown; Chapter 3). 
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To examine the erythroid potential of each of the populations in Figure 2.1A, in 
vitro methylcellulose culture was performed.  FACS sorted cells from the four quadrants 
were plated independently in an erythroid inducing environment with SCF, IL-2 and EPO 
supplements.  Erythroid colonies were detected with benzidine staining.  The results 
indicated that the cells from all four populations produced a significant number of 
erythroid colonies early during the culture period.  However, only the CD62L–Thy1.1+ 
population maintained a persistent number of erythroid colonies for the duration of the 
observation period, while the other three populations showed reduced numbers of 
erythroid colonies as days progressed (Figure 2.1C).  The presence of strong and 
persistent erythroid colonies from CD62L–Thy1.1+ population indicated that it had 
greater erythroid progenitors than the other three populations and suggested that it may 
contain HSC. 
 
CD62L– fraction of KLS contains  
the HSC population 
 
In order to investigate the presence of HSC in the CD62L+ and CD62L– fractions 
in vivo, we performed a transplant experiment.  GFP+HbbS mice were used as donors to 
allow for the tracking of platelets and white blood cells (WBC) produced from the 
transplanted populations via flow cytometric analysis.  Red blood cells (RBC) were 
tracked via hemoglobin variant HbbS via HPLC analysis.  1000 donor KLS cells were 
sorted according to CD62L expression (Figure 2.2A and 2.2B).  The donor cells were 
transplanted into lethally irradiated GFP–HbbD recipient mice with 100K cells of 
recipient type as competitors. 
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 The transplant data showed that CD62L– cells reconstituted the hematopoietic 
system of the recipient mice strongly and persistently (Figure 2.1C~E).  In contrast, 
CD62L+ cells failed to engraft persistently.  They did generate cells of all lineages, 
however, the donor-derived cells diminished significantly during the weeks 
posttransplant.  More specifically, platelets were undetectable shortly after the transplant, 
RBC level was stronger but did completely disappear by week 13, while WBC 
diminished to a very low level after the initial burst, but persisted throughout the entire 
observation period.  When transplanted, HSC would be expected to generate progenies 
for the life of the recipient, since HSC has the capacity to self-renew.  It is also expected 
that it will produce progenies in all lineages.  MPP, on the other hand, while expected to 
produce cells of all lineages, is not expected to produce them for the life of the animal 
with their limited capacity for self-renewal.  In addition, their progeny output is expected 
to be less than that of HSC.  One aspect of MPP that is expected to surpass HSC in a 
transplant setting is the temporal kinetics of progeny production.  Considering the fact 
that MPP is a more mature population than HSC, it is logical that MPP would 
differentiate into progeny cells quicker than HSC, which must pass through the MPP 
stage first.  In agreement with this concept, the data showed that RBC level peaked prior 
to week 3 for CD62L+ cells, however, CD62L– cells did not peak in RBC production 
until week 5 (Figure 2.2D).  Together, the data suggest that the CD62L– population 
contained HSC, while the CD62L+ population contained MPP. 
 To confirm that the CD62L– population contains HSC, the bone marrow cells of 
the recipient mice were examined following the termination of transplant observation.  
Harvested bone marrow cells of CD62L+ recipients were stained with C-kit and Sca-1 to 
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analyze the KLS compartment for GFP+ donor cells (Figure 2.3A).  Only a trace amount 
of GFP+ cells were found (<0.1%, Figure 2.3B).  In contrast, the bone marrow cells of 
the CD62L– recipients showed a significant level of GFP+ cells (Figure 2.3C and 2.3D).  
On average, 45% of KLS cells in these animals were donor-derived cells.  The GFP+ 
KLS cells were then isolated by FACS sorting and transplanted into another set of 
lethally irradiated hosts.  Since CD62L+ recipients generated only trace amounts of 
GFP+ cells in their KLS fractions, all GFP+ cells were pooled into one injection and 
given to one recipient.  Five weeks later, the hosts’ peripheral blood samples were 
analyzed for donor-derived cells.  Only mice receiving CD62L– donor-derived GFP+ 
cells produced GFP+ progenies (Figure 2.3E).  The mouse receiving CD62L+ donor-
derived GFP+ cells did not produce any detectable amount of cells in any lineages.  
These results confirm that CD62L– fraction contained HSC and CD62L+ fraction 
contained MPP.  In addition, the data indicate that the long term tracking of peripheral 
blood is sufficient for the determination of donor HSC or MPP identities. 
 
The CD62L– fraction is enriched for HSC, while 
the CD62L+ fraction is enriched for MPP 
 
 In the primary transplant of the preceding experiment, an equal number of 1000 
cells was transplanted for both CD62L– and CD62L+ fractions.  Therefore, a reasonable 
follow up question was to inquire if there are different frequencies of HSC present in 
CD62L– and CD62L+.  If CD62L+ contained a rare population of HSC, then it may not 
have been detectable at 1000 donor cells.  Therefore we repeated the above experiments 
using different numbers of donor cells.  The CD62L– fraction was given to the transplant 
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recipients at 100 cells per recipient, while the CD62L+ fraction was given to the 
recipients at 10,000 cells per recipient.  All other parameters remained the same as above. 
 The analysis of RBC confirmed our previous findings.  The CD62L– fraction, 
despite the few donor cells injected, produced a strong and persistent output of RBC, 
while the CD62L+ fraction, despite the overwhelming number of progenitors injected, 
produced RBC that diminished over time until they became undetectable (Figure 2.4A).  
Consistent with the large number of cells injected, the CD62L+ population did produce 
more RBC than did the CD62L– fraction early in the time course.  Similarly to figure 
2.2D, the CD62L+ progenitors also peaked in RBC production earlier than the CD62L– 
HSC.  WBC analysis showed results similar to the previous experiment, confirming the 
identities of the CD62L– and CD62L+ populations as HSC and MPP, respectively 
(Figure 2.4B). 
 To investigate if both populations of cells conferred radioprotection, the 
transplant recipient mice were lethally irradiated.  500 cells per CD62L fraction were 
injected into the mice without any competitors.  The results showed that donor cells of 
both fractions successfully rescued all mice treated with progenies detectable in the 
peripheral blood, subsequently, with similar kinetics as observed above (Figure 2.4C and 
2.4D).  
  
Different frequencies of HSC are observed in  
CD62L– fractions within Sca-1 subsets 
 
 While the above data indicated convincingly that CD62L– fraction of KLS 
contained HSC, a concern arose if CD62L– HSC can be obtained by gating on Sca-1HIGH 
fraction without the actual use of CD62L.  As discussed previously, Sca-1 is a marker of 
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stem cells.  Therefore it was possible that HSC undergoing differentiation may express 
CD62L after Sca-1 is downregulated.  While this scenario would support the hypothesis 
that CD62L is a marker of hematopoietic differentiation, it would also limit the value of 
CD62L as a marker for HSC purification.  Hence, the KLS population was 
subfractionated into Sca-1HIGH and Sca-1LOW subsets for transplantation (Figure 2.5A).  
No obvious differences in Flt3 and Thy1.1 expression patterns were observed for the two 
Sca-1 subsets (Figure 2.5B and 2.5C).  The known HSC-containing population, Flt3–
Thy1.1+, was gated and analyzed for CD62L in both Sca-1HIGH and Sca-1LOW subsets 
(Figure 2.5D and 2.5E).  As one might expect, the Sca-1HIGH fraction of HSC contained 
very few CD62L+ cells, approximately 6% (Figure 2.5D).  The Sca-1LOW fraction of 
HSC, however, contained a significant number of CD62L+ cells, approximately 38% 
(Figure 2.5E).  The CD62L– cells of Sca-1HIGH fraction (SHIGH) and CD62L– cells of Sca-
1LOW fraction (SLOW) cells were sorted and transplanted into lethally irradiated mice at 
1000 cells per donor fraction with 100K competitor cells, as previously performed. 
 Subsequent peripheral blood analysis for RBC and WBC production indicated 
that both populations contained significant amounts of HSC (Figure 2.5F and 2.5G).  
RBC production was strong from both populations, and toward the end of observation 
period at week 16, there was no statistically significant difference observed between the 
outputs of RBC (Figure 2.5F).  Interestingly, a significant difference was observed in 
WBC engraftment during the late term.  While almost all WBC found in SHIGH recipients 
were of donor origin, approximately 90%, only about 20% of WBC found in SLOW 
recipients were of donor origin (Figure 2.5G).  From these results, it is unclear exactly 
how different the stem cell frequencies are between SHIGH and SLOW populations.  It is a 
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conservative claim, however, that SHIGH is likely to contain a higher frequency of HSC 
than SLOW.  The data also suggest that the SLOW population is biased for erythroid lineage 
engraftment.  Clonal analysis would be required to confirm these interpretations. 
 
The CD62L– fraction of KLSF– is the 
primary site of HSC enrichment 
 
 Flt3 is a widely used marker for FACS-sorting of HSC.  The well established 
three early hematopoietic populations of KLS, LT-HSC, ST-HSC and MPP are based on 
the expression pattern of Flt3 and Thy1.1 (Morrison et al., 1997; Adolfsson et al., 2001; 
Christensen and Weissman, 2001).  Therefore, if CD62L is to be established as a marker 
useful for purifying HSC, it must be tested in the context of Flt3.  To examine the 
efficacy of CD62L in purifying HSC within the Flt3-defined parameter, CD62L– and 
CD62L+ fractions of Flt3– fraction of KLS (KLSF–) were sorted (Figure 2.6A and 2.6B).  
The CD62L profile of the KLSF– population indicated a significant portion of CD62L+ 
cells, approximately 28% (Figure 2.6C).  2000 cells per fraction were transplanted into 
lethally irradiated recipients with 100K competitor cells.   
 Peripheral blood analysis for engraftment activity showed strong engraftment in 
all lineages by the CD62L– fraction, reconstituting approximately 90% across the 
lineages (Figure 2.6D~F).  In contrast, the CD62L+ fraction showed a persistent but weak 
engraftment.  Platelet engraftment diminished to approximately 10% at the end of the 
analysis period (Figure 2.6D).  RBC engraftment was approximately 20% (Figure 2.6E).  
WBC engraftment was similar to platelet engraftment at approximately 10% (Figure 
2.6F).  These results indicate that CD62L+ may contain a small number of HSC.  The 
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few HSC activity observed may also be a product of contamination from the neighboring 
CD62L– population.   
 To determine how significant the HSC activity in CD62L+ fraction was, 
repopulating units (RU) was calculated based on the transplant experiment.  The RU 
calculation is a commonly used method to quantify the frequency of repopulating cells in 
comparison to a known quantity, often competitor cells of whole bone marrow (Harrison, 
1980; Purton and Scadden, 2007).  The formula for RU calculation is: donor RU = % 
donor cells * C/(100 - % donor cells), where C = the number of competing RU (Harrison, 
1980).  100K whole bone marrow cells are equivalent to 1 competing RU (Harrison et al., 
1993; Yuan et al., 2005).  It has been our observation that platelet engraftment was most 
consistent with the presence of HSC among all the transplant experiments; therefore, the 
platelet data was applied for the calculation.  The actual value of platelet engraftment at 
the end of analysis period was 7.7% (Figure 2.6D).  Hence, the formula is: donor RU = 
7.7 * 1 / (100 – 7.7).  The calculated donor RU for CD62L+ fraction is 0.083.  In 
comparison, the donor RU for CD62L– fraction is 5.7 (85% donor cells, Figure 2.6D).  
The ratio of CD62L+ RU to CD62L–RU is 1:68.   
This is an overestimation of CD62L+ RU in vivo as CD62L+ cells are not present 
as frequently as CD62L– cells in the KLSF– fraction.  As indicated, CD62L+ cells 
constitute 28% of KLSF–.  Adjusting for the actual cell frequency in vivo, the adjusted 
CD62L+ RU to CD62L– RU comes to 1:175, meaning that for every HSC present in the 
CD62L+ fraction, there are 175 HSC in the CD62L– fraction.  Therefore, approximately 
0.57% of the total HSC in the KLSF– population belong in the CD62L+ fraction, while 
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the rest >99% of HSC belong in the CD62L– fraction.  Therefore, we conclude that the 
CD62L– fraction of the KLSF– population represents the primary source of HSC. 
 
Discussion 
In this report, we have presented in vivo evidence for HSC enrichment using 
CD62L as a marker.  While there are numerous markers for HSC isolation already, the 
quest for the purest form of HSC continues.  Current advances in fluorescence-activated 
cell sorter technology have emphasized the need for expansion of known surface markers 
of HSC to obtain live samples.  The extent of purity we will achieve will depend on the 
availability and specificity of various markers.   
One of the popular methods of HSC enrichment method is the application of 
Hoechst 33342.  It has been demonstrated that a distinct population of bone marrow cells 
was capable of efficient Hoechst 33342 efflux (Goodell et al., 1996).  This population has 
been called the side population and has been described as HSC enriched population.  A 
recent study, however, demonstrated that CD34–KLS cells contain similar frequencies of 
HSC in both the side population and in the non-side population, as determined by 
Hoechst 33342 (Morita et al., 2009).  
Flt3 is a widely accepted tool for the isolation of HSC.  The expression profile of 
Flt3 in conjunction with Thy1.1 resolve the three early hematopoietic compartments, LT-
HSC, ST-HSC and MPP that has formed the foundation of our current understanding of 
early hematopoietic events in adult mice (Morrison et al., 1997; Adolfsson et al., 2001; 
Christensen and Weissman, 2001).  Interestingly, a recent report indicated that ST-HSC 
as defined by the Flt3 and Thy1.1 expression pattern is not entirely limited in its capacity 
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for self-renewal (Colvin et al., 2009).  In fact, it was reported that ST-HSC engrafted for 
a year when transplanted, and engrafted for as long as three months in secondary 
transplants.     
Thy1.1, while effective for the isolation of HSC within KLS, is limited in the 
Thy1.1 expressing strains of mice as mice expressing the more common Thy1.2 allele do 
not express the marker on most HSC (Spangrude and Brooks, 1992). 
 These findings emphasize the need for ongoing investigation of current markers 
as well as exploration for new markers to advance our ability to isolate HSC and 
understand HSC biology.  We have presented in vivo evidence for CD62L as an 
attractive alternative to Flt3 or a supplemental marker to be used in combination with 
currently known markers for an improved purification of HSC.  Our transplant data 
demonstrated that CD62L fractionation of KLS yields a CD62L– HSC population and a 
CD62L+ MPP population (Figure 2.2 and 2.3).  This is supported by persistent versus 
transient engraftment observations described above.  We have also observed temporal 
kinetic differences appropriate for transplant experiments using MPP and HSC, as MPP-
derived progenies are expected to arrive sooner than HSC-derived progenies (Figure 2.4A 
and 2.4B). 
 Additionally our data support the model that the regulation of expression of stem 
cell markers changes gradually as hematopoietic development progresses gradually.  The 
fractionation of KLS HSC into Sca-1LOW and Sca-1HIGH fraction has shown that the more 
immature Sca-1HIGH fraction contained a greater frequency of the CD62L– population 
compared to the Sca-1LOW fraction (Figure 2.5D and 2.5E, respectively), supporting our 
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claim that CD62L is a marker of hematopoietic differentiation.  In vivo engraftment data 
also supported this model (Figure 2.5F and 2.5G). 
 In comparison to Flt3, our data show that CD62L fractionation yielded CD62L– 
and CD62L+ populations within the Flt3– fraction (Figure 2.6C).  The identification of 
heterogeneity within the Flt3– population suggests three conclusions: (1) Flt3– HSC in 
KLS is not a homogenous population, (2) MPP-containing CD62L+ fraction within the 
Flt3– fraction can be eliminated to yield a purer HSC population, and (3) as there are 
Flt3+CD62L– cells that are most likely to lack HSC, concomitant application of Flt3 and 
CD62L is highly desirable for HSC purification.  Our report did not investigate the in 
vivo potential of Flt3+CD62L– population of KLS.  Such an experiment is warranted to 
confirm the utility of combinations of Flt3 and CD62L antibodies as a tool for dissection 




Mice carrying the Thy1.1 and Ly5.1 alleles on the C57BL background were 
generated in our animal facility by mating the BKa.AK-Thy1a/Ka and B6.SJL-Ptprca 
Pep3b/BoyJ strains and selecting for cosegregation of Thy1.1 and Ly5.1 (GFP–
Thy1.1+HbbS mice).  GFP transgenic mice, generated by microinjection of C57BL/6 
oocytees, were kindly provided by Dr. Masaru Okabe (Osaka University, Osaka, Japan) 
(Nakanishi et al., 2002).  In these mice, the GFP transgene is driven by the chicken β-
actin promoter and is expressed in all lineages except in the erythroid lineage.  Hence, 
hemoglobin variant alleles (HbbS and HbbD) were used to track erythroid engraftment 
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(see below).  In order to generate donor mice for transplant studies, we have crossed the 
GFP transgenic mice with GFP–Thy1.1+HbbS mice to generate GFP+Thy1.1+HbbS mice.  
B6.Cg-Gpi1a HbbD H1b/DehJ mice (Harrison et al., 1988) were kindly provided by Dr. 
David Harrison (Jackson Laboratory, Bar Harbor, ME, USA).  These mice are GFP–
Thy1.1–HbbD and were used as transplant recipients.  All mice were kept in the animal 
resources center at the University of Utah under the institutional animal care and use 
committee approved protocols. 
 
Antibodies 
Monoclonal antibodies against CD2 (Rm2.2), CD3 (KT3-1.1), CD5 (53-7.3), 
CD8 (53-6.7), CD11b (M1/70), Ly-6G (RB6-8C5), TER119, B220 (CD45R; RA3-6B2), 
and CD19 (1D3) were purified from the media of cultured hybridoma cell lines. PE-
conjugated Sca-1 monoclonal antibody was purchased from PharMingen (San Diego, CA, 
USA).  C-kit (3C11) monoclonal antibody was purified and conjugated to Alexa Fluor 
647 in our laboratory.  CD4 and CD8 monoclonal antibodies were purified and 
conjugated to allophycocyanin (APC).  Biotinylated Flt3, CD62L APC-AF750, Thy1.1 
PerCP-Cy5.5, Mac-1 PE and Gr-1 PE antibodies were purchased from eBioscience (San 
Diego, CA, USA).  
 
Isolation of hematopoietic progenitors and stem cells 
 In order to remove mature cells from the harvested whole bone marrow cells, 
lineage depletion was performed.  The cells were incubated with a cocktail of rat 
antibodies to mature cell markers (CD2, CD3, CD5, CD8, CD11b, Ly-6G, TER119, 
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B220 and CD19).  Secondary labeling of mature cells was performed by two successive 
incubations with magnetic beads-coupled sheep anti-rat antibodies (Dynal, Oslo, 
Norway).  Each incubation was followed by a depletion step of the labeled cells using a 
magnetic column (Dynal, Oslo, Norway).  The depleted cells were stained with various 
fluorochrome-conjugated antibodies as indicated in the figures to electronically visualize 
and sort using FACS Aria instrument (BD Immunocytometry Systems, San Jose, CA, 
USA).  DAPI was used to discriminate dead cells from live cells. 
 
Bone marrow transplantation 
 The GFP–Thy1.1–HbbD recipient mice were lethally irradiated a day prior to the 
transplant day (137Cs, 13 Gy delivered in a 3 hour-split dose).  Isolated 
GFP+Thy1.1+HbbS donor cells were injected into the recipients retro-orbitally.  The 
recipient mice were anesthetized with isoflurane using the E-Z Anesthesia system for the 
injection (Euthanex Corp., Palmer, PA).   
 
Peripheral blood analysis 
 For the posttransplant analysis, peripheral blood samples were collected from the 
retro-orbital sinus with heparinized capillary tubes.  The mice were anesthetized with 
isoflurane using the E-Z Anesthesia system (Euthanex Corp., Palmer, PA).  Immediately 
after the collection of blood samples, 10 ul of blood per sample were set aside for platelet 
analysis.  The rest of the samples were mixed with 500ul of 2% Dextran T500 
(Amersham Biosciences, Piscataway, NJ) in PBS and incubated at 37 degree C for 30 
min for sediment separation of the RBC and WBC fractions.  The RBC fraction was 
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processed for HPLC analysis (see below).  WBC were stained with PE-conjugated 
antibodies against Mac-1 and Gr-1 for myeloid WBC detection, Biotinylated B220 or 
CD19 antibody with a subsequent labeling with Alexa Fluor 750-conjugated avidin for B 
cell detection, and CD4 and CD8 conjugated with APC for T cell detection.  Platelets and 
WBC were analyzed by FACScan flow cytometer (BD Biosciences, San Jose, CA; 
modified by Cytek Development, Fremont, CA).  Platelet analysis was performed by 
increasing forward and side scatter parameters until the platelet population could be gated 
to exclude contaminants. 
  
HPLC analysis of hemoglobin variants 
A HPLC cation exchange protocol was developed in our laboratory to 
discriminate and quantify HbbD and HbbS in the peripheral blood samples (Spangrude et 
al., 2006).  A stock solution of 100 mM 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) 
(Sigma-Aldrich, St. Louis, MO) was prepared by dissolving 100 mg of DTNB in 2.5 ml 
of DMSO and stored at –20 degree C.  The RBC fraction was derivatized by adding 5 ul 
of the RBC fraction into 250ul of 40 mM NaCl and 2 mM DTNB and incubating at room 
temperature for 30 minutes.  Following centrifugation at 12,000 g for 2 minutes, the 
supernatant were analyzed using a VARIANT hemoglobin testing system (Bio-Rad 
Laboratories, Hercules, CA) with an optimized β–thalassemia short program. 
 
In vitro erythroid potential assay 
 To assay clonal erythroid potential, 200 cells per sorted population were plated on 
35 mm culture dish in alpha-modified Eagle’s medium-based methylcellulose containing 
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10% fetal calf serum, 10% deionized bovine serum albumen, antibiotics, l-glutamine, and 
2-mercaptoethanol.  Erythroid development was promoted by supplementing the cultures 
with stem cell factor (SCF, 100 ng/ml), interleukin-3 (IL-3, 10 ng/ml), and erythropoietin 
(EPO, 4 U/ml).  Periodically, a subset of cultures was stained using benzidine 
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Figure 2.1  CD62L expression pattern in early hematopoietic progenitors.  Panel A  
Flow cytometric analysis of the hematopoietic stem cell compartment (KLS) is shown.  
The KLS cells were labeled with antibodies against CD62L and Thy1.1.  The percentages 
indicate the amount of cells per quadrant.  Panel B  The KLS cells were labeled with 
antibodies against Flt3 and Thy1.1.  The percentages indicate the amount of cells per 
quadrant.  The labels indicate the progenitor identities as previously defined.  Panel C  
Fluorescence-activated cell sorting was used to isolate pure cells from each quadrant of 
panel A for an in vitro experiment.  Two-hundred cells per methylcellulose dish were 
grown with cytokines for erythroid development: SCF, IL-3 and EPO.  Periodically a 
subset of plates was analyzed with benzidine staining for erythroid colonies.  The values 
indicate the percentage of erythroid colonies per plate observed at each time point.  The 
quadrant labels in the legend indicate T+L+ for Thy1.1+CD62L+, T+L– for 










































































































Figure 2.2  In vivo evidence for HSC in the CD62L– population of KLS.  Panel A  
Mature cell-depleted whole bone marrow was labeled with antibodies against C-kit and 
Sca-1 to visualize KLS via flow cytometry for sorting.  Panel B  A histogram of CD62L 
expression within the KLS population as gated in panel A.  The percentages indicate the 
frequency of KLS cells belonging to the CD62L– and CD62L+ fractions.  The two 
fractions were sorted for transplant.  For each fraction, 1000 cells were injected into five 
lethally irradiated recipients with 100K whole bone marrow cells of the recipient type as 
competitors.  The donor-derived cells in peripheral blood were tracked via GFP 
expression for platelets and white blood cells (WBC) through flow cytometry.  Red blood 
cells were tracked through the hemoglobin variant HbbS using HPLC.  Panel C  Platelet 
output from the injected fractions are shown.  CD62L+ cells produced a transient, small 
but detectable amount of platelets early during the posttransplant analysis period.  Panel 
D and E  RBC and WBC productions are shown as indicated.  CD62L+ cells produced a 
transient output of RBC as platelets, albeit stronger.  WBC production decreased over 
time but persisted until the end of the analysis period.  The CD62L– fraction produced 



































































Figure 2.3  Confirmation of CD62L– HSC engraftment.  Following the last peripheral 
blood analysis at week 13 of posttransplantation, the transplant recipients shown in 
Figure 2.1 were sacrificed and their bone marrow cells analyzed for the presence of 
donor-derived cells in the KLS population.  Panel A  Whole bone marrow flow 
cytometric analysis of transplant recipients that received the CD62L+ donor fraction.  
Panel B  Early hematopoietic stem and progenitor cells of the KLS population as gated in 
panel A.  Only a trace amount of GFP+ donor-derived cells was detected.  The 
percentages indicate the frequency of GFP– competitor-derived cells and GFP+ CD62L+ 
donor-derived cells.  Panel C  Whole bone marrow analysis of mice that received the 
CD62L– fraction.  Panel D  Early hematopoietic stem and progenitor cells of the KLS 
population as gated in panel C.  A significant portion of KLS were donor-derived GFP+ 
cells.  The percentages indicate the average percentages found across all recipients of 
CD62L– fraction.  Panel E  GFP+ KLS cells of CD62L– fraction-transplant recipients 
were sorted and transplanted into lethally irradiated secondary recipients.  The trace 
amounts of GFP+ KLS cells of CD62L+ fraction-transplant recipients were pooled 
together and transplanted into one lethally irradiated secondary recipient.  Five weeks 
posttransplant, the peripheral blood analysis was performed.  The average amounts of 
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Figure 2.4  In vivo evidence for enrichment of HSC in CD62L– fraction and MPP in 
CD62L+ fraction of KLS.  To further substantiate the CD62L-mediated fractionation of 
HSC and MPP, two bone marrow transplants were conducted.  The first transplant 
experiment consisted of transplanting 100 cells per CD62L– fraction and 10K cells per 
CD62L+ fraction with 100K competitor cells as performed previously.  Five lethally 
irradiated recipients per fraction were used.  Panel A  Engraftment was detected via RBC 
analysis.  Both fractions showed strong engraftment early.  By the end of analysis at 
week 16, the CD62L+ fraction failed to maintain RBC production.  Panel B  WBC 
analysis is shown.  Similar results as RBC were observed, however, the CD62L+ fraction 
maintained a measurable amount of WBC output.  The second experiment consisted of 
transplanting 500 cells per fraction into four lethally irradiated mice per fraction without 
any competitors to test for each fraction’s capability for hematopoietic rescue.  Panel C  
All mice from both fractions were successfully rescued from lethal irradiation.  RBC 
analysis showed a similar engraftment pattern seen in panel A.  Panel D  WBC analysis 
showed a persistent but severely reduced engraftment by the CD62L+ fraction.  The 
CD62L– fraction had nearly completely reconstituted the hematopoietic system of 
































































Figure 2.5  Presence of HSC activity in both Sca-1HIGHand Sca-1LOW fractions of 
KLS.  Panel A  In order to determine whether HSC enrichment via CD62L is isolated to 
immature cells expressing high levels of Sca-1, KLS were subfractionated into Sca-1HIGH 
and Sca-1LOW as indicated.  Panel B  Flt3 and Thy1.1 expression pattern of KLS was 
analyzed to gate for Flt3–Thy1.1+ HSC population for Sca-1HIGH fraction.  Panel C  As 
in panel B, Flt3–Thy1.1+ HSC population is gated for Sca-1LOW fraction.  Panel D  
CD62L expression profile of HSC gated in panel B is shown.  The percentages indicate 
the frequencies of CD62L+ and CD62L– cells.  CD62L– cells are labeled as SHIGH (Sca-
1HIGHHSC population).  1000 SHIGH cells were sorted and transplanted into five lethally 
irradiated mice with 100K competitors.  Panel E  As in panel D, SLOW (Sca-1LOWHSC 
population) is indicated for a similar transplant experiment.  Panel F  RBC engraftment 
data of SHIGH and SLOW transplanted mice are shown.  Both groups exhibited persistent 
RBC engraftment.  Panel G  As in panel E, persistent WBC engraftments from SHIGH and 
SLOW recipients were observed.  In contrast to RBC data, WBC activity by SLOW was 











































































Figure 2.6  HSC activity is primarily enriched in the CD62L–Flt3–Thy1.1+ KLS 
fraction.  Panel A  A representative flow cytometric analysis of mature cell-depleted 
bone marrow is shown with KLS gating.  Panel B  A representative Flt3 Thy1.1 profile 
of KLS is shown with HSC population gated.  Panel C  CD62L expression of Flt3– 
population is shown.  The percentages indicate the amounts of CD62L– and CD62L+ 
cells within the Flt3– compartment.  The CD62L– and CD62L+ fractions (KLSF–
CD62L– and KLSF–CD62L+) as indicated were sorted, and 2000 cells per fraction were 
transplanted into five lethally irradiated mice with 100K competitor cells.  Panel D  
Platelet engraftment by the two fractions are shown.  The KLSF–CD62L+ population 
showed a weak but persistent platelet production.  Panel E  Similarly to platelets, the 
KLSF–CD62L+ population showed a weak but persistent RBC production.  Panel F  
WBC production also showed a weak but persistent output for the KLSF–CD62L+ 
fraction received cells.  The KLSF–CD62L– fraction almost completely reconstituted the 















































































IN VIVO EVIDENCE FOR HETEROGENIETY AMONG  
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A traditionally described hematopoietic multipotent progenitor is a non-self 
renewing progenitor that is capable of generating cells of all hematopoietic lineages.  
This progenitor has been labeled as the most mature population of the hematopoietic stem 
cell compartment prior to the segregation of lymphoid and myeloid lineages.  In this 
report, we test the hypothesis that the multipotent progenitor population is a 
heterogeneous population and that CD62L, an adhesion molecule, is a marker of early 
hematopoietic differentiation that can subfractionate the multipotent progenitor 
population into functionally distinct subpopulations.  We present evidence demonstrating 
that the multipotent progenitor population contains phenotypically distinct 
subpopulations according to expression levels of CD62L and Sca-1.  In vivo transplant 
data demonstrate that the multipotent progenitor subpopulations experience significant 
reduction in erythro-megakaryocyte potential as they upregulate CD62L and 
downregulate Sca-1.  Furthermore, the data show that as multipotent progenitors 
upregulate CD62L, a greater fraction of their progenies become T cell biased, while 
maintaining a significant B cell output.  
 
Introduction 
In an adult mouse, hematopoiesis originates from a subset of immature cells in the 
bone marrow.  This subset, which includes hematopoietic stem cells (HSC) and 
multipotent progenitors (MPP), is identified by a shared expression pattern of surface 
markers: (1) they lack a set of mature hematopoietic cell surface proteins (designated 
collectively as lineage or Lin), and (2) they express high levels of hematopoietic stem 
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cell-associated markers c-Kit and Sca-1 (Spangrude et al., 1988; Ikuta and Weissman, 
1992).  Accordingly, this subset of immature cells is conveniently labeled as the 
hematopoietic stem cell compartment or KLS for c-Kit+, Lin– and Sca-1+.   
The hematopoietic stem cell compartment is further fractionated into three 
functionally distinct subpopulations based on the expression levels of surface molecules, 
Thy1.1 and Flt3: Thy1.1+ Flt3– long-term HSC (LT-HSC), Thy1.1+ Flt3+ short-term 
HSC (ST-HSC), and Thy1.1– Flt3+ MPP (Spangrude et al., 1988; Morrison et al., 1997; 
Adolfsson et al., 2001; Christensen and Weissman, 2001).  Currently, it is widely 
accepted that only the most primitive LT-HSC maintains the capacity to self-renew for 
the life of the animal and gives rise to ST-HSC, a more mature population of progenitors 
with limited capacity for self-renewal.  The most mature population of KLS, the MPP, 
which lacks the capacity to self-renew but still maintains multipotency, is generated last 
(Spangrude et al., 1988; Morrison et al., 1997; Adolfsson et al., 2001; Christensen and 
Weissman, 2001). 
The three population model of KLS is useful for the purpose of describing the 
events of early hematopoiesis; however, it is over simplified.  As KLS is being studied 
with increasing scrutiny to delineate the early progression of hematopoiesis, further 
evidence has emerged that demonstrate the complex heterogeneity within the 
subpopulations.  The traditional description of lineage specification occurs outside KLS 
with the bifurcation of lymphoid and myeloid lineages through the establishment of 
common lymphoid progenitors (CLP) (Kondo et al., 1997) and common myeloid 
progenitors (CMP) (Akashi et al., 2000) in the bone marrow.  Emerging data, however, 
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strongly suggest the loss of and/or bias toward specific hematopoietic lineages occurring 
within the MPP of KLS, prior to the stages of CLP and CMP.   
One example is a study describing the existence of lymphoid-primed multipotent 
progenitors (LMPP) (Adolfsson et al., 2005).  The study identifies LMPP in the 
hematopoietic stem cell compartment as the population of cells that expresses the highest 
level of Flt3, constituting a significant fraction of MPP (approximately the top 25% of 
KLS cells for Flt3 expression).  Unlike the MPP cells, which have significant output in 
all hematopoietic lineages, the LMPP cells generated insignificant numbers of platelets 
and red blood cells, suggesting the loss of erythro-megakaryocytic lineage (Meg/E) 
potential prior to cells exiting the hematopoietic stem cell compartment and 
demonstrating the existence of partially multipotent progenitors within the pool of true 
multipotent progenitors.  A subsequent study by another group showed that while LMPP 
cells do have a detectable amount of Meg/E activity, it is significantly less than that of 
MPP, thereby contrasting the previous report’s claim of loss of Meg/E activity, while 
confirming the existence of heterogeneity within the MPP population (Forsberg et al., 
2006).   
The MPP population has also been subfractionated using the vascular cell 
adhesion molecule-1 (VCAM-1).  In these studies, the MPP population is divided into 
VCAM-1+ and VCAM-1– populations.  Their results show that VCAM-1+ MPP 
generated cells of all lineages like the traditional MPP cells, however, VCAM-1– MPP 
failed to generate Meg/E potentially as robustly as the MPP cells or the VCAM-1+ MPP, 
similar to the above-mentioned LMPP (Lai et al., 2005; Lai and Kondo, 2006).  
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It should be noted that the investigators also observed that VCAM-1– MPP cells 
express high levels of Flt3, while VCAM-1+ MPP cells express both low and high levels 
of Flt3 (Lai and Kondo, 2006).  This finding is consistent with the concept of LMPP that 
within the traditionally described Flt3+ MPP, heterogeneity of multipotency exists based 
on the actual expression level of Flt3 as demonstrated with the loss of Meg/E potential 
(Adolfsson et al., 2005).  Furthermore, these observations suggest that there are other 
markers, such as VCAM-1, that may be useful in identifying functionally distinct 
subpopulations within the MPP (Akashi et al., 2005; Lai and Kondo, 2006) 
Our laboratory has previously demonstrated that the Thy1.1– portion of KLS 
(KLST–) can be divided using CD62L, also known as the cell adhesion molecule CD62L, 
to produce functionally distinct subpopulations.  When so divided, CD62L– KLST– cells 
behaved as a traditional MPP, generating T cells, B cells, and white blood cells of 
myeloid lineage (monocytes and granulocytes), while CD62L+ KLST– resembled an 
early T-lineage progenitor with wavelike thymic seeding kinetics and transient B cell 
generation and little myeloid potential (Perry et al., 2004).  Therefore, CD62L is an 
effective marker for studying lineage commitment and heterogeneity within early 
hematopoietic progenitors. 
In the following experiments, we expand upon our previous research using 
CD62L and Sca-1.  We have hypothesized that CD62L is a marker of early hematopoietic 
development and that CD62L can be used to isolate distinct subpopulations within the 
traditional MPP.  To test our hypothesis, the Thy1.1– Flt3+ MPP of the hematopoietic 
stem cell compartment was subfractionated into CD62L+ and CD62L– fractions.  These 
subpopulations were then further divided according to low and high expression levels of 
 56
Sca-1 (Sca-1LO and Sca-1HI).  In accordance with our hypothesis, we predicted that the 
CD62L–Sca-1HI population would be the most primitive progenitor population and that 
the CD62L+Sca-1LO population would be the most mature progenitor population within 
the MPP compartment. 
Using a novel HPLC protocol for hemoglobin analysis developed in our 
laboratory and GFP-expressing mice as progenitor donors for transplant, we present in 
vivo evidence for heterogeneity within the traditional Thy1.1– Flt3+ MPP population.  
The data presented here demonstrate that each of the subpopulations defined by CD62L 
represents a functionally distinct hematopoietic progenitor population that signifies a 
transition stage during early hematopoietic development. 
 
Results 
Phenotypically distinct subpopulations suggest  
heterogeneity within the MPP population 
In order to test our hypothesis that CD62L-based subfractionation can 
demonstrate heterogeneity within the MPP population, we analyzed the hematopoietic 
stem cell compartment using flow cytometry.  Cells of the hematopoietic stem cell 
compartment, denoted as KLS, was identified as lineage-depleted bone marrow cells 
gated for c-KitHigh and Sca-1+, and were labeled with Flt3 and Thy1.1 antibodies to 
display the traditional division of KLS into LT-HSC, ST-HSC and MPP (Figure 3.1A).  
Combined labeling of Flt3 and CD62L revealed a high degree of co-expression, since 
26% of cells expressed neither marker and 49% of cells expressed both markers (Figure 
3.1B).  This high degree of co-expression pattern is particularly interesting considering 
the previous evidence which demonstrated that variable expression levels of Flt3 
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correlated with variable capacity for multipotency among Flt3+ MPP (Forsberg et al., 
2006; Lai and Kondo, 2006).  Also, the presence of cells that are mutually exclusive for 
the expression of CD62L and Flt3 suggested potential functionally distinct populations 
that would not be identifiable without the use of CD62L as a marker. 
To proceed with the isolation of subpopulations, the Thy1.1– fraction from the 
KLS were gated to subdivide them into Flt3+ CD62L+ and Flt3+ CD62L- populations 
(CD62L+ MPP and CD62L– MPP, respectively) (Figure 3.1A and 3.1C).  While the 
majority of these cells were CD62L+ MPP, a significant fraction of cells were detected as 
CD62L– MPP (approximately 5:1 CD62L+ MPP to CD62L– MPP).  Finally the two 
MPP populations were subfractionated into Sca-1LO and Sca-1HI populations as outlined 
in Figure 3.1D.  These four subpopulations were not flow cytometry artifacts, as after 
they were sorted, they were reanalyzed to confirm their identity (data not shown). 
The receptor for interleukin 7, frequently detected using an antibody raised 
against its α-chain (IL7Rα), has been reported to be upregulated in more mature 
lymphoid progenitors (CLP), and has been described as a marker of lymphoid 
development (Kondo et al., 1997).  We were, however, able to detect minute numbers of 
IL7Rα+ cells within the various subpopulations of KLS.  Not surprisingly, the lowest 
number of IL7Rα+ cells was detected in the least mature LT-HSC population, while the 
more mature MPP population contained a greater number of IL7Rα+ cells (Figure 3.2).  
In agreement with our hypothesis that CD62L expression is a marker of hematopoietic 
development, the CD62L+ cells had the greater number of IL7Rα+ cells than the 
CD62L– cells (Figure 3.2) when the MPP were subfractionated into CD62L+ and 
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CD62L– fractions as identified in Figure 3.1C.  The IL7Rα data, along with Flt3-CD62L 
co-expression data, imply the capacity of CD62L to identify distinct MPP subpopulations. 
 
CD62L and Sca-1 subfractionated populations  
show distinct Meg/E potential in vivo 
In order to assess the hematopoietic potential of the four subfractionated MPP 
populations in vivo (CD62L– Sca-1HI, CD62L– Sca-1LO, CD62L+ Sca-1HI, CD62L+ Sca-
1LO), the target populations were isolated via fluorescence-activated cell sorter from 
GFP+HbbS donor mice.   For each population, 3000 cells were sorted and transplanted 
via retro-orbital injection into lethally irradiated GFP–HbbD mice.  The donor cells were 
injected, along with 250k whole bone marrow cells from GFP–HbbD mice as competitors 
to comparatively quantify the amounts of engraftment among donor populations.  
Peripheral blood samples of the transplant recipients were periodically analyzed to 
identify and quantify progenies of specific lineages.  To assess Meg/E potential, 
megakaryocyte production was identified by the presence of GFP+ donor platelets 
detected via flow cytometry, and the erythroid potential was identified by the presence of 
the donor hemoglobin variant HbbS via HPLC.  To assess myeloid potential, GFP+ 
monocytes and granulocytes were detected via flow cytometry.  
 Over the course of 9 weeks, the transplanted populations displayed varying 
amounts Meg/E potential.  CD62L–Sca-1HI cells, suspected to include the least mature 
progenitor population among the four, generated a large spike of platelets detected at 
week two, while the other three populations generated trace amounts of donor platelets 
early on (Figure 3.3A).  As expected, all four progenitor populations generated platelets 
only temporarily, dropping to undetectable amounts by week six.  The largest amount of 
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donor-derived RBC was also detected from CD62L–Sca-1HI recipients (Figure 3.3B).  
The CD62L+Sca-1LO population, suspected to include the most mature progenitors, 
generated the lowest amount of RBC among the four progenitors.  CD62L–Sca-1LO and 
CD62L+Sca-1HI cells generated moderate amounts of RBC compared to the other two 
populations, suggesting that they represent transitional populations between the less 
mature CD62L–Sca-1HI and the more mature CD62L+Sca-1LO populations.  The dramatic 
reduction of Meg/E potential observed as progenitors shifted from CD62L–Sca-1HI to 
CD62L+Sca-1LO is consistent with the idea that upregulation of this developmental 
marker is accompanied by loss of capacity for progeny production.  This observation 
parallels other studies that also showed the reduction of Meg/E potential with the 
changing expression of other developmental antigens (Flt3 and VCAM-1) as discussed 
above (Adolfsson et al., 2005; Lai and Kondo, 2006).  We did not observe any 
statistically significant difference among the four populations in myeloid potential, 
suggesting that myeloid potential stands independently from Meg/E potential among 
these populations (Figure 3.3C). 
 
CD62L  subfractionated populations show  
differential T cell  potential bias  in vivo 
 
The peripheral blood analysis of the transplant recipients revealed significant 
differences in the amounts of lymphoid progenies generated from the subfractionated 
populations of the KLS MPP.  All populations generated robust numbers of B cells early 
on and gradually lost the capacity to replenish.  However, as with the Meg/E potential, 
CD62L–Sca-1HI generated the greatest amount of B cells, while CD62L+Sca-1LO 
generated the least amount (Figure 3.4A).  The other two populations generated 
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intermediate numbers of B cells.  This observation indicates that B cell potential 
decreases as early hematopoietic progenitors upregulate CD62L and downregulate Sca-1. 
Interestingly, T cell potential did not follow the same pattern seen in B cell 
potential.  T cells, having to migrate from bone marrow to thymus before maturation, did 
not peak in production until after week four.  We observed that CD62L–Sca-1HI and 
CD62L+Sca-1HI populations both generated large amounts of T cells, while CD62L–Sca-
1LO and CD62L+Sca-1LO populations generated lesser amounts of T cells (Figure 3.4B).  
The observation that progenitor populations characterized by the Sca-1HI phenotype 
generated similarly large amounts of T cells, regardless of CD62L levels, indicates that 
Sca-1 expression level indicates T cell potential, independently of CD62L.  However, 
based on previous data (Perry et al., 2004), we suspected that a potentially subtle lineage 
commitment bias detectable by CD62L may have been further diluted by Sca-1 
segregation.  Therefore, we combined the progeny output data according to CD62L 
expression to result in CD62L+ and CD62– data only.  The ratio of cell numbers 
generated for each cell type from CD62L+ to CD62L– progenitors was then calculated 
(Table 3.1A).  The analysis confirmed our previous observation that Meg/E potential 
diminishes with the increased expression of CD62L.  For every single platelet and RBC 
generated by CD62L+ progenitors, approximately two platelets and RBC were generated 
by CD62L– progenitors as indicated by the average ratio for platelets of 1:2.2 and for 
RBC of 1:2.0.  We also detected a minor bias toward T cell potential.  As indicated by the 
average ratio of 1:0.7, for every T cell generated by CD62L+ progenitors, only 0.7 T cell 
were generated by CD62L– progenitors. 
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 By analyzing the number of B cells generated per T cell generated, we were able 
analyze all four CD62L and Sca-1 fractionated populations for T cell bias according to 
CD62L expression (Table 3.1B).  CD62L+Sca-1HI and CD62L+Sca-1LO populations 
generated 1 T cell per 21 and 20 B cells generated, respectively.  CD62L–Sca-1HI and 
CD62L–Sca-1LO generated 1 T cell per 29 and 33 B cells generated, respectively.  
Regardless of Sca-1 level, CD62L+ progenitors consistently generated more T cells per B 
cell than CD62L– progenitors, demonstrating a T cell bias among CD62L-expressing 
progenitors within their lymphoid capacity.  A similar bias toward T cell was also 
observed when the number of myeloid cells per T cell generated was analyzed. 
 
Comparable frequencies of erythroid progenitors  
exist among the subpopulations 
 
Despite our efforts to identify specific subpopulations that constitute the 
heterogeneity of KLS MPP, we recognize that even our subpopulations are likely to be 
heterogeneous themselves and that not every progenitor cell in any given subpopulation 
contributes equally to the reconstitution of specific lineages.  Therefore, clonal analysis 
of each subpopulation was conducted by plating 200 progenitors per population in 
methylcellulose medium and supplementing with erythroid promoting cytokines to 
determine the frequency of erythroid progenitors.  From culture day 5 to 11, every 2 days, 
colonies of cells, representing single seeder progenitors, were stained with benzidine to 
identify erythroid colonies.  The assay revealed that all four subpopulations generated 
similar numbers of erythroid colonies, and that the numbers of erythroid colonies 
diminished over time, disappearing almost completely by the end of the assay at day 11 
(Figure 3.5).  On the other hand, the positive control population, KLS Thy1.1LO HSC 
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demonstrated persistent production of erythroid colonies.  This result does not reflect the 
dramatic differences in erythroid potential observed in the transplant experiment shown 
in Figure 3.3B.  The apparent contradiction of the two experiments may indicate that the 
erythroid progenitors present in the subpopulations may have different capacity for 
progeny production.  That is, while CD62L–Sca-1HI and CD62L+Sca-1LO populations 
may have similar numbers of erythroid progenitors, CD62L–Sca-1HI may contain more 
robust erythroid progenitors than CD62L+Sca-1LO and generate more RBC over time. 
 
CD62L subfractionation of KLS MPP  
may not be substituted by Flt3 
 
We have demonstrated that subfractionation of KLS MPP using CD62L along 
with Sca-1 resulted in functionally distinct subpopulations.  Our experiments were 
designed around CD62L, because we have hypothesized it to be a marker of early 
hematopoiesis like Flt3.  In support of this concept, we have demonstrated that CD62L 
and Flt3 have a substantial degree of co-expression pattern as seen in Figure 3.1B.  A 
relevant follow up question is to inquire whether CD62L adds additional resolution of 
functional subsets of progenitor cells over those obtained with Flt3.  A flow cytometric 
measurement of Flt3 expression levels by CD62L+ and CD62L– MPP revealed that Flt3 
may not substitute CD62L.  The mean fluorescence of Flt3 for CD62L+ MPP was 208, 
and the mean fluorescence of Flt3 for CD62L– MPP was 194, presenting a virtually 
indistinguishable amount of difference in Flt3 expression (Figure 3.6).  Hence, CD62L 
stands as a unique marker of early hematopoietic differentiation that may be used to 
identify distinct subpopulations of KLS MPP and provide further evidence for 
heterogeneity within this traditional MPP population. 
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Discussion 
In this report, we have expanded upon previous findings that described CD62L as 
an effective marker for dividing the KLST– fraction of the hematopoietic stem cell 
compartment into a CD62L+ fraction, which resembled an early T-lineage progenitor, 
and a CD62L– fraction, which resembled the traditional MPP (Perry et al., 2004).  The 
bone marrow transplant results, however, had been restricted to the engraftment of white 
blood cells only, since the tool used to differentiate the donor-derived hematopoietic cells 
from the cells of the recipient mice was allele-specific antibody labeling of CD45, a 
surface marker that is expressed on white blood cells (WBC), but not on platelets or red 
blood cells (Spangrude et al., 1988; Perry et al., 2004).  Therefore, previous studies did 
not identify Meg/E potential in the two fractions of MPP.   
In order to test our hypothesis that CD62L is a marker of hematopoietic 
differentiation and that CD62L can be used to demonstrate the heterogeneity within the 
traditionally defined multipotent progenitor population, we have conducted transplant 
experiments using subfractionated MPP according to CD62L and Sca-1 levels.  The use 
of mouse strains that express GFP along with a variant of the hemoglobin beta-chain 
(HbbS) allows for the tracking of engraftment activity in all hematopoietic lineages: 
Meg/E lineage, myeloid linage among WBC and lymphoid lineage among WBC. 
Our results showed that not only there are subfractions of KLS MPP that are 
distinguishable by surface expression levels of CD62L and Sca-1, but also that these 
subpopulations are functionally distinct.  Our in vivo transplant experiments have 
demonstrated that CD62L–Sca-1HI population had the most robust activity in all lineages, 
while the CD62+Sca-1LO population exhibited significantly less production of T cells, B 
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cells, platelets and RBC.  In fact, platelets and RBC produced by CD62L+Sca-1LO cells 
were barely detectable and only early on during the weeks following the transplant, even 
though the production of T cells, B cells, monocytes and granulocytes of myeloid lineage 
was relatively strong.  This is consistent with the other reports demonstrating that there 
are subpopulations within KLS MPP with significantly less Meg/E activity than the 
commonly described MPP (Adolfsson et al., 2005; Lai and Kondo, 2006). 
We have also demonstrated that with the upregulation of CD62L, the multipotent 
progenitors develop a relative T cell lineage bias.  As described in Table 3.1, all four 
populations generated more B cells and myeloid WBC than T cells.  Only by carefully 
analyzing the shift in the portions of progenies among different subpopulations of MPP, 
we were able to identify an increase in the portion of progenies that resulted as T cells 
and thereby revealing a subtle T cell bias among the CD62L+ subpopulations.  This is 
inconsistent with our previous findings that the CD62L+ fraction constituted a more 
pronounced T cell bias (Perry et al., 2004).  This discrepancy may be due to the different 
sorting strategy we utilized in this report.  The previous study divided the entire KLST– 
into CD62L+ and CD62L– fractions.  We, however, have divided the KLS MPP, that is 
KLST–Flt3+, into CD62L+ and CD62L–.  Therefore, the previous study’s CD62L+ and 
CD62L– fractions included cells of the phenotype KLST–Flt3–.  Prior to the execution of 
the experiments, we have hypothesized that the exclusion of KLST–Flt3– would not 
make a significant difference, as we have seen.  As seen in Figure 3.1A, vast majority of 
KLST– falls into KLS MPP fraction and only a small fraction resides in the Flt3– fraction.  
Therefore, we considered the Flt3– portion to be too few to have an impact.   
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Upon retrospect, the KLST–Flt3– may contain hematopoietic progenitors that 
may be relevant to the discussion of early hematopoietic development.  The Flt3+ 
compartment of KLS contains almost 1:4 CD62L– to CD62L+ cells (Figure 3.1B).  The 
same figure reveals that the Flt3– compartment contains approximately 2:1 CD62– to 
CD62L+ cells.  If our hypothesis of CD62L being a marker of development is correct, 
then the Flt3– fraction may represent a pool of significant progenitors that may be 
upstream of Flt3+ progenitors. 
Interestingly there are other markers reported to subfractionate the KLS 
compartment into distinct subpopulations.  A set of mature cell markers that are typically 
eliminated during the depletion of mature hematopoietic cells, CD4 and Mac-1, have 
been implicated in the subfractionation of KLS (Morrison and Weissman, 1994).  
Another set of markers, the Slam family proteins (CD150, CD244 and CD48) have been 
also reported to be fractionate KLS into HSC and MPP (Kiel et al., 2005; Forsberg et al., 
2005).  Another interesting marker that has been used to isolate HSC and fractionate KLS 
is CD34, a ligand for CD62L (Osawa et al., 1996; Yang et al., 2005).  The co-expression 
pattern of these markers with CD62L is unknown.  Future investigations into the 
relationship of CD62L expression with these other markers would be interesting, and 
may yield new subpopulations that may represent acute transition stages, granting a better 
understanding of early hematopoietic events at higher resolution.   
Surprisingly, our data suggest that the frequencies of erythroid-capable 
progenitors are similar among the four subpopulations as shown in the in vitro 
methylcellulose assay.  This is in an apparent contradiction with our in vivo transplant 
data showing that with CD62L upregulation and Sca-1 downregulation, the progenitors 
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lose dramatic amount of Meg/E potential.  One explanation may be that the progenitors 
lose the extent of Meg/E capability at the level of individual cells, rather than as a 
population.  In that case, the frequency of erythroid progenitors may stay relatively stable 
as the progenitor population matures; however, the amount of actual RBC produced per 
progenitor may be reduced.  Another possibility is the artificial nature of in vitro cultures.  
In vitro experiments, which may be informative under the appropriate conditions and 
necessary in some cases, have been shown to force hematopoietic progenitors to develop 
into progenies of unnatural lineages under certain conditions (Nutt et al., 1999; Rolink et 
al., 1999). 
Collectively, our data demonstrate that CD62L, despite having an expression 
pattern that is similar to that of Flt3, is able to identify functionally distinct 
subpopulations of MPP that would be impossible with the use of Flt3 alone.  Furthermore, 
the data support the model of heterogeneous KLS MPP that sheds Meg/E potential, 
marked by the upregulation of CD62L, prior to the lymphoid and myeloid lineage 




Mice carrying the Thy1.1 and Ly5.1 alleles on the C57BL background were 
generated in our animal facility by mating the BKa.AK-Thy1a/Ka and B6.SJL-Ptprca 
Pep3b/BoyJ strains and selecting for cosegregation of Thy1.1 and Ly5.1 (GFP–
Thy1.1+HbbS mice).  GFP transgenic mice, generated by microinjection of C57BL/6 
oocytees, were kindly provided by Dr. Masaru Okabe (Osaka University, Osaka, Japan) 
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(Nakanishi et al., 2002).  In these mice, the GFP transgene is driven by the chicken β-
actin promoter and is expressed in all lineages except in the erythroid lineage.  Hence, 
hemoglobin variant alleles (HbbS and HbbD) were used to track erythroid engraftment 
(see below).  In order to generate donor mice for transplant studies, we have crossed the 
GFP transgenic mice with GFP–Thy1.1+HbbS mice to generate GFP+Thy1.1+HbbS mice.  
B6.Cg-Gpi1a HbbD H1b/DehJ mice (Harrison et al., 1988) were kindly provided by Dr. 
David Harrison (Jackson Laboratory, Bar Harbor, ME, USA).  These mice are GFP–
Thy1.1–HbbD and were used as transplant recipients.  All mice were kept in the animal 
resources center at the University of Utah under the institutional animal care and use 
committee approved protocols. 
 
Antibodies 
Monoclonal antibodies against CD2 (Rm2.2), CD3 (KT3-1.1), CD5 (53-7.3), 
CD8 (53-6.7), CD11b (M1/70), Ly-6G (RB6-8C5), TER119, B220 (CD45R; RA3-6B2), 
and CD19 (1D3) were purified from the media of cultured hybridoma cell lines. PE-
conjugated Sca-1 monoclonal antibody was purchased from PharMingen (San Diego, CA, 
USA).  C-kit (3C11) monoclonal antibody was purified and conjugated to Alexa Fluor 
647 in our laboratory.  CD4 and CD8 monoclonal antibodies were purified and 
conjugated to allophycocyanin (APC).  Biotinylated Flt3, CD62L APC-AF750, Thy1.1 
PerCP-Cy5.5, Mac-1 PE and Gr-1 PE antibodies were purchased from eBioscience (San 




Isolation of hematopoietic progenitors and stem cells 
 In order to remove mature cells from the harvested whole bone marrow cells, 
lineage depletion was performed.  The cells were incubated with a cocktail of rat 
antibodies to mature cell markers (CD2, CD3, CD5, CD8, CD11b, Ly-6G, TER119, 
B220 and CD19).  Secondary labeling of mature cells was performed by two successive 
incubations with magnetic beads-coupled sheep anti-rat antibodies (Dynal, Oslo, 
Norway).  Each incubation was followed by a depletion step of the labeled cells using a 
magnetic column (Dynal, Oslo, Norway).  The depleted cells were stained with various 
fluorochrome-conjugated antibodies as indicated in the figures to electronically visualize 
and sort using FACS Aria instrument (BD Immunocytometry Systems, San Jose, CA, 
USA).  DAPI was used to discriminate dead cells from live cells. 
 
Bone marrow transplantation 
 The GFP–Thy1.1–HbbD recipient mice were lethally irradiated a day prior to the 
transplant day (137Cs, 13 Gy delivered in a 3 hour-split dose).  Isolated 
GFP+Thy1.1+HbbS donor cells were injected into the recipients retro-orbitally.  The 
recipient mice were anesthetized with isoflurane using the E-Z Anesthesia system for the 
injection (Euthanex Corp., Palmer, PA).   
 
Peripheral blood analysis 
 For the posttransplant analysis, peripheral blood samples were collected from the 
retro-orbital sinus with heparinized capillary tubes.  The mice were anesthetized with 
isoflurane using the E-Z Anesthesia system (Euthanex Corp., Palmer, PA).  Immediately 
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after the collection of blood samples, 10 ul of blood per sample were set aside for platelet 
analysis.  The rest of the samples were mixed with 500ul of 2% Dextran T500 
(Amersham Biosciences, Piscataway, NJ) in PBS and incubated at 37 degree C for 30 
min for sediment separation of the RBC and WBC fractions.  The RBC fraction was 
processed for HPLC analysis (see below).  WBC were stained with PE-conjugated 
antibodies against Mac-1 and Gr-1 for myeloid WBC detection, Biotinylated B220 or 
CD19 antibody with a subsequent labeling with Alexa Fluor 750-conjugated avidin for B 
cell detection, and CD4 and CD8 conjugated with APC for T cell detection.  Platelets and 
WBC were analyzed by FACScan flow cytometer (BD Biosciences, San Jose, CA; 
modified by Cytek Development, Fremont, CA).  Platelet analysis was performed by 
increasing forward and side scatter parameters until the platelet population could be gated 
to exclude contaminants. 
  
HPLC analysis of hemoglobin variants 
A HPLC cation exchange protocol was developed in our laboratory to 
discriminate and quantify HbbD and HbbS in the peripheral blood samples (Spangrude et 
al., 2006).  A stock solution of 100 mM 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) 
(Sigma-Aldrich, St. Louis, MO) was prepared by dissolving 100 mg of DTNB in 2.5 ml 
of DMSO and stored at –20 degree C.  The RBC fraction was derivatized by adding 5 ul 
of the RBC fraction into 250ul of 40 mM NaCl and 2 mM DTNB and incubating at room 
temperature for 30 minutes.  Following centrifugation at 12,000 g for 2 minutes, the 
supernatant were analyzed using a VARIANT hemoglobin testing system (Bio-Rad 
Laboratories, Hercules, CA) with an optimized β–thalassemia short program. 
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In vitro erythroid potential assay 
 To assay clonal erythroid potential, 200 cells per sorted population were plated on 
35 mm culture dish in alpha-modified Eagle’s medium-based methylcellulose containing 
10% fetal calf serum, 10% deionized bovine serum albumen, antibiotics, l-glutamine, and 
2-mercaptoethanol.  Erythroid development was promoted by supplementing the cultures 
with stem cell factor (SCF, 100 ng/ml), interleukin-3 (IL-3, 10 ng/ml), and erythropoietin 
(EPO, 4 U/ml).  Periodically, a subset of cultures was stained using benzidine 
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Figure 3.1    Flow cytometric subfractionation of the hematopoietic stem cell 
compartment (KLS).  Panel A  Representative profile of Flt3 and Thy1.1 expression 
within the hematopoietic stem cell compartment.  The KLS population, identified as 
lineage-depleted bone marrow cells gated for c-KitHigh and Sca-1+, was subfractionated 
as LT-HSC, ST-HSC and MPP according to the expression levels of Flt3 and Thy1.1.  
Panel B  CD62L and Flt3 co-expression profile of KLS.  The percentages indicate the 
portion of cells belonging to each quadrant of KLS.  Panel C  The KLST– population, 
identified as the Thy1.1– portion of KLS as indicated by the dashed box and arrow from 
panel A, was analyzed by CD62L and Flt3 expressions and further subfractionated into 
CD62L+ MPP and CD62L– MPP.  Panel D  Representation of target populations for 
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Figure 3.2    IL7Rα+ cells among hematopoietic stem cells and early hematopoietic 
progenitors.   Traditionally viewed early hematopoietic populations are listed in the 
order of maturity from LT-HSC to MPP.  The amount of IL7Rα+ cells per population 
was quantified by flow cytometric analysis to demonstrate the degree of lymphoid 
differentiation per population.  CD62L+ MPP (CD62L-neg MPP) and CD62L– MPP 
(CD62L-pos MPP) are subfractionated populations of MPP via CD62L expression.  The 
common lymphoid progenitor (CLP) represents the most mature population and is the 
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Figure 3.3    Assessment of myeloid lineage output of transplanted subfractionated 
MPP populations.  MPP of KLS were subfractionated via FACS sorting according to 
CD62L and Sca-1 levels as indicated in Figure 3.1C and Figure 3.1D.   3000 sorted donor 
progenitors were transplanted with 250k recipient whole bone marrow cells as 
competitors into 4 to 5 lethally irradiated recipients, which were periodically analyzed for 
engraftment via retro-orbital bleeding.  Error bars represent SEM.  Panel A  Donor-
derived platelets were measured among total platelets in the peripheral blood via flow 
cytometry.  CD62L– Sca-1HI progenitors (triangle) showed the most robust early platelet 
production compared to CD62L+ Sca-1LO progenitors (square) (P<0.02).  By week 6, 
donor platelets were undetectable or nearly undetectable.  Panel B  Donor-derived RBC 
were measured via HPLC analysis.  Consistent with the platelet engraftment data, 
CD62L– Sca-1HI (triangle) demonstrated the greatest potency for RBC generation.  Panel 
C  Monocytes and granulocytes were analyzed via flow cytometry and measured as cells 
of the myeloid lineage among total white blood cells in the peripheral blood.  High 
variations per sample led to statistical insignificance among various donor groups.  SEM 

























































































Figure 3.4    Assessment of lymphoid lineage output of transplanted subfractionated 
MPP populations.  MPP of KLS were subfractionated via FACS sorting according to 
CD62L and Sca-1 levels as indicated in Figure 3.1C and Figure 3.1D.   3000 sorted 
progenitors were transplanted into 4 to 5 lethally irradiated recipients with 250k recipient 
whole bone marrow cells as competitors and periodically analyzed for engraftment via 
retro-orbital bleeding and FACS analysis.  Error bars represent SEM.  Panel A  B cell 
engraftment was analyzed by quantifying the amount of donor B cells from the total 
peripheral blood WBC.  B cell production peaked early at week 2 and decreased over 
time, during which CD62L– Sca-1HI progenitors (triangle) maintained the greatest B cell 
production compared to CD62L+ Sca-1LO progenitors (square) which had the least 
amount of activity (p<0.01).  Panel B  T cell engraftment was quantified from the total 
peripheral WBC.  The amount of T cell production depended on the progenitors separated 
by Sca-1, regardless of CD62L expression.  The greatest difference came from CD62L+ 


















































































Table 3.1    T cell lineage bias among subfractionated MPP populations.  Part A  To 
detect any lineage bias among MPP populations isolated by CD62L expression, the ratios 
of mature cells produced by CD62L+ to CD62L– progenitors were determined per 
lineage.  The ratios were determined from the time points that showed the most robust 
progeny production.  CD62L– progenitors had greater number of progenies produced in 
all lineages compared to CD62L+ progenitors, except in T cell lineage.  Part B  T cell 
output was compared to B cell output and M cell output per progenitor population by 
dividing the number of B cells or M cells by the number of T cells per indicated time 
period.  Peak* indicates the analysis of progeny numbers taken from the time points of 
their greatest production per lineage.  The peak times were week 2 for M lineage, week 4 
for B lineage, and week 6 for T lineage for all progenitors, except CD62L+ Sca-1LO, for 
which the peak time for T lineage was week 4.  The numbers indicate the number of M 































Progeny Cell Type Weeks Posttransplant 
    
Average 
    2 3 4 6 9   
   Ratio of CD62L+ to CD62L– progenies   
Platelets  1:3.1  1:1.3     1:2.2 
RBC  1:1.7  1:2.4  1:2.0  1:1.8   1:2.0 
M Cells  1:1.6  1:1.0     1:1.3 
B Cells  1:1.1  1:1.6  1:1.5    1:1.4 








Progenitor Weeks Posttransplant 
  
    4 6 9 Peak* 
   Number of B cells / 1 T cell generated 
CD62L– Sca1-HI 44 12 8.1 29 
CD62L– Sca1-LO 33 5.1 4.9 33 
CD62L+ Sca1-HI 15 5.9 4.3 21 
CD62L+ Sca1-LO 5.6 3.1 2.4 20 
   
 
Number of M cells / 1 T cell generated 
CD62L– Sca1-HI 1.4 0.4 0.4 2.5 
CD62L– Sca1-LO 1.3 0.5 0.6 6.0 
CD62L+ Sca1-HI 0.3 0.3 0.3 1.3 















Figure 3.5    Clonal analysis for erythroid lineage.  Clonal RBC potential was 
determined for each MPP population in vitro.  200 Sorted progenitors per population 
were grown in methylcellulose and promoted to erythroid development by supplying the 
cells with stem cell factor (SCF), interleukin-3 (IL-3), and erythropoietin (EPO).  
Periodically the colonies were stained with benzidine, a highly selective hemoglobin 
detection agent to identify erythroid activity.  HSC indicated as Thy1.1LO were used as a 
positive control.  The error bars are SEM.  No statistically significant difference was 









































































Figure 3.6    Flt3 expression levels in CD62L-subfractionated MPP.  Flow cytometric 
analysis was performed to determine the Flt3 expression levels in CD62L– (black) and 
CD62L+ (gray) MPPs.  Mean fluorescence (MF) for each population is indicated.  




























































































IDENTIFICATION OF CD62L-EXPRESSING MULTIPOTENT 
 
PROGENITORS OUTSIDE THE TRADITIONAL  
 




































 The end stage progenitor within the hematopoietic stem cell compartment is a 
multipotent progenitor population that expresses high levels of c-Kit, Sca-1, CD62L and 
Flt3.  We have attempted to identify the next stage progenitor in the previously 
characterized myeloid progenitor compartment that expresses high level of c-Kit but 
lacks Sca-1.  Within this population we have identified a subset that is phenotypically 
identical to the multipotent progenitor population of the hematopoietic stem cell 
compartment with the exception of Sca-1 expression.  Transplant experiments 
demonstrate that this subset within the myeloid progenitor compartment exhibits 
multipotency, albeit weaker than the multipotent progenitors that express Sca-1.  A 
myeloid committed progenitor population was also identified by the lack of CD62L and 




All blood cells are generated from hematopoietic stem cells (HSC) in the bone 
marrow.  As the HSC matures, it loses its capacity for self-renewal and passes through a 
multipotent progenitor stage (MPP). The pool of HSC and MPP cells have been identified 
to share common expression patterns of Sca-1 and c-Kit, and have been named the 
hematopoietic stem cell compartment ( or KLS) (Spangrude et al., 1988; Ikuta and 
Weissman, 1992; Christensen and Weissman, 2001).   
 A traditional model of hematopoietic lineage commitment occurs outside the KLS 
stage with the bifurcation of lymphoid and myeloid lineages as common lymphoid 
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progenitors (CLP) (Kondo et al., 1997) and common myeloid progenitors (CMP) (Akashi 
et al., 2000) are formed.  This model was further substantiated with subsequent studies 
tracing the lymphoid lineage to CLP (Miller et al., 2002; Martin et al., 2003).  However, 
this model has been recently disputed.  Recent studies of the MPP of KLS have revealed 
the formation of lymphoid lineage bias and the significant reduction of 
erythroid/megakaryocyte lineage (Meg/E) (Adolfsson et al., 2005; Lai et al., 2005; Lai 
and Kondo, 2006).  Our laboratory has also discovered in vitro and in vivo evidence for 
similar loss of Meg/E potential and lymphoid bias (Chapter 3; Perry et al., 2004; Kwak et 
al., 2007).  Together, the results indicate the shift in lineage potential within the MPP 
population, prior to the CLP and CMP stages.   
 To further complicate the model, significant myeloid progenies have been 
generated from CLP, a population once considered to be composed of pure lymphoid 
progenitors (Balciunaite et al., 2005; Rumfelt et al., 2006).  Previously it was 
demonstrated that T cell progenitors found in the adult murine thymus lacked B cell 
potential (Porritt et al., 2004; Lu et al., 2005).  Later studies, however, have shown that 
even these T progenitors maintained some capacity for macrophage production in vitro, 
indicating that B cell potential may be lost before myeloid potential has been completely 
lost from the lymphoid lineage (Bell and Bhandoola, 2008; Wada et al., 2008).  
Additionally, the preservation of macrophage production capability has been observed in 
what was previously thought as B cell progenitors in the bone marrow (Montecino-
Rodriguez et al., 2001). 
 In 2000, Akashi et al. described the group of cells that exhibited a high level of c-
Kit expression and no Sca-1 expression (KLS–) just outside the KLS as the myeloid 
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progenitor population (Akashi et al., 2000).  In that study they further classified three 
populations out of the myeloid progenitor population according to the surface expression 
levels of CD34 and FcγR: (1) CD34+FcγRLO as the CMP that gave rise to all myeloid 
cells, (2) CD34+FcγRHI as the GMP for granulocyte/macrophage restricted progenitors, 
and (3) CD34–FcγRLO as the MEP for megakaryocyte/erythroid restricted progenitors 
(Akashi et al., 2000).  Another group, however, has demonstrated subsequently that CMP, 
when transplanted to sublethally irradiated recipients through intrasplenic or intravenous 
injections, have produced B cells (Yang et al., 2005) and that these B cells were 
functionally distinct from CLP-derived B cells (Yang et al., 2007).  These results show 
that the commonly described lineage segregation of lymphoid and myeloid lineages 
through CLP and CMP have been overly simplified and the need for further studies to 
elucidate the lineage commitment steps. 
 Previously our laboratory has reported that CD62L is an excellent candidate to 
study the hematopoietic differentiation process by demonstrating that CD62L-
fractionated Thy1.1– fraction of KLS led to the identification T cell-biased MPP (Perry et 
al., 2004).  We have also demonstrated that HSC lacked CD62L expression (Chapter 2).  
Subsequently we have demonstrated with in vivo evidence that MPP of KLS have lost a 
significant amount of Meg/E potential, developed T-cell bias, and weakened in overall 
progeny production as the cells upregulated CD62L and downregulated Sca-1 (Chapter 3).  
These observations indicate that CD62L is upregulated as hematopoiesis proceeds from 
HSC, and hence is an excellent marker of early differentiation.   
In this report, we have opted to follow the CD62L expression outside KLS in 
order to study the KLS– fraction of bone marrow that contains myeloid progenitors.  By 
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isolating subpopulations through fluorescence-activated cell sorting, transplant 
experiments were performed to assess their in vivo lineage potentials.  The results 
demonstrate that CD62L expression is maintained by a subset of myeloid progenitors and 
that this population exhibits rare lymphoid activity.  A minute, but detectable amount of 
T cell lineage is also shown through in vitro cultures.  Together, the results indicate 




KLS– myeloid progenitors include a population 
phenotypically similar to KLS MPP 
 
 Development of the myeloid lineage proceeds from KLS, which contains HSC 
and MPP, to a Sca-1– c-KitHigh population which contains CMP, GMP and MEP (Akashi 
et al., 2000) as shown in figure 4.1A.  Previously we have observed that the most mature 
population of KLS was the CD62L+Flt3+Sca-1Low MPP that has lost much of Meg/E 
potential and developed lymphoid bias (Chapter 3).  The implication of these three 
markers regarding to hematopoietic differentiation is that CD62L and Flt3 were 
upregulated as Sca-1 was downregulated by the early hematopoietic stem cells and 
progenitors in the KLS compartment as they matured.  Therefore, it was reasonable to 
inquire if this trend continued outside KLS.  Following the decreasing trend of Sca-1, we 
have targeted the KLS– compartment for the identification of the closest progenitor 
population to KLS MPP.   
 KLS– cells were stained with antibodies against CD62L and Flt3.  We have 
observed roughly three populations according to the expression profile: CD62L+Flt3+ 
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(++), CD62L+Flt3– (+–), and CD62L–Flt3– (--) (Figure 4.1B).  Out of the three 
populations, CD62L+Flt3+ appeared closest to the MPP of KLS, differing only in Sca-1 
expression and sharing the same c-Kit, CD62L and Flt3 expressions, leading to the 
hypothesis that CD62L+Flt3+ was the most proximal progenitor population to KLS MPP 
outside KLS. 
 
Multipotent progenitor activity is observed  
from the pool of myeloid progenitors 
 
In order to assess lineage potentials of the three populations in vivo, a transplant 
experiment was performed.  Sorted 100K cells per population were injected into lethally 
irradiated recipients.  Donor cells in peripheral blood were identified by flow cytometric 
analysis.  RBC analysis was performed through HPLC for the quantification of the HbbS 
hemoglobin variant for the donor RBC and the HbbD hemoglobin variant for the recipient 
RBC.  Platelet output was the greatest from the CD62L–Flt3– population, CD62L+Flt3+ 
population generated a less, but strong, RBC output early on, and CD62L+Flt3– 
population generated a weak output (Figure 4.2A).  Platelet output from all populations 
diminished over time, however, platelet output from CD62L–Flt3– persisted the most.  
RBC generation was strong from all three populations, with the output from 
CD62L+Flt3– being the weakest (Figure 4.2B).  The results indicate that CD62L+Flt3+ 
and CD62L–Flt3– retained a substantial Meg/E potential, while CD62L+Flt3– had nearly 
lost Meg potential and maintained only erythroid potential.   
From the analysis of myeloid leukocytes, we observed that CD62L+Flt3+ had the 
strongest output, while CD62L–Flt3– generated an intermediate amount with 
CD62L+Flt3– generating only a weak early burst of activity, similar to its platelet activity 
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(figure 4.3C).  These data demonstrate CMP-like activity from CD62L+Flt3+ and 
CD62L–Flt3–.  The CD62L+Flt3– population appears mostly erythroid-biased in the 
myeloid lineage. 
To assess lymphoid potential, B cell and T cell output was measured.  In either 
case only the CD62L+Flt3+ population generated significant levels of B and T cells with 
the other two donor populations generating only barely detectable trace amounts of B and 
T cells (Figure 4.2D and Figure 4.2E).  Together, the data indicate that the CD62L–Flt3– 
population behaves as the CMP population and that the CD62L+Flt3– population as 
mostly an erythroid progenitor.  The CD62L+Flt3+ population, with strong multipotency 
in all lineages, resembled the KLS MPP.  Since the only phenotypic marker difference 
between CD62L+Flt3+ and KLS MPP is the presence of Sca-1, and since CD62L+Flt3+ 
exhibited multipotency in vivo, the CD62L+Flt3+ population will hereafter be referred to 
as KLS– MPP.    
 
 
The KLS– MPP subset exhibits limited activity  
compared to the traditional KLS MPP 
 
 The multipotent activity of KLS– MPP had not been expected, since the KLS– 
compartment has been described to be entirely composed of myeloid progenitors and 
their progenies (Akashi et al., 2000).  Therefore, to further characterize the multipotency 
of KLS– MPP in vivo, a competitive transplant experiment between KLS– MPP and KLS 
MPP was conducted.  Target cells were sorted by fluorescence-activated cell sorting.  
Sorted 2000 cells of KLS– MPP were injected together with 2000 cells of KLS MPP into 
sublethally irradiated recipient mice.  Lethal irradiation of transplant recipients will cause 
death if the donor cells do not rescue the recipient’s hematopoietic system.  Since the 
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donor cells were composed only of MPP and excluded HSC, we utilized sublethal 
radiation doses in order to avoid any deaths due to hematopoietic failure.  In order to 
distinguish among KLS– MPP progenies, KLS MPP progenies and the native 
hematopoietic cells in the peripheral blood, we employed GFP/Ly5.1 donor mice for 
KLS– MPP, GFP–/Ly5.1 mice for KLS MPP, and GFP–/Ly5.2 mice for recipients.  
Ly5.1 marker was detected with the anti-Ly5.1-FITC antibody.  This allowed for the 
observation of cells from the three mouse strains in one fluorescence parameter (Figure 
4.3A).  The native cells would be negative for GFP and Ly5.1 staining.  The KLS MPP-
derived cells would be in the intermediate Ly5.1 positive only cells.  The KLS– MPP-
derived cells would express GFP and would appear as the brightest peak; the contribution 
of Ly5.1-FITC to the bright fluorescence of GFP is minimal.  Unfortunately, this 
experimental design allowed for the observation of white blood cells only, since RBC or 
platelets do not express Ly5.1 or Ly5.2 (Spangrude et al., 1988). 
 The transplant results showed that KLS MPP exhibited a strong activity in 
myeloid leukocytes, B cells and T cells compared to KLS– MPP, which showed only a 
weak early transient output of B cells with no significant myeloid or T cells (Figure 
4.3B~D).  The deficiency in MPP activity from KLS– MPP may be due to the fewer 
number of cells transplanted, since in the previous experiment, 100K cells were used per 
transplant compared to only 2000 cells in this experiment.  The other possibility is that 
KLS– MPP cells could not compete against KLS MPP cells for engraftment, and were 
not able to generate enough progenies for detection above the background of the 
progenies of the KLS MPP population.  If there is only a limited space in the bone 
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marrow for stem cells and progenitors to occupy, then naturally there would be a 
competition for these niches (Schofield, 1978; reviewed in Yin and Li, 2006).   
 
Multipotent progenitor activity is severely diminished 
following transplant of low numbers of KLS– MPP 
 
To investigate if competition between KLS– MPP cells and KLS MPP cells 
resulted in a significant loss of activity, 2000 KLS– MPP cells were transplanted into 3 
lethally irradiated hosts with 250K whole bone marrow competitor cells of the recipient-
type.  In order to minimize any possibility of contamination, the cells were double sorted 
to achieve >99% purity with 0% contamination from KLS cells.  Out of the three 
recipient mice, only mouse #2 showed a significant activity in all lineages, while the 
other two mice similarly showed significant output in only RBC and B cells (Figure 
4.4A~E). 
The presence of RBC and B cell output in all three lineages suggest that KLS– 
MPP contains at least erythroid/B cell bipotent progenitors.  While CMP’s capacity to 
produce B cells (Yang et al., 2005; Yang et al., 2007) and B cell progenitors exhibiting 
capacity for macrophage production (Montecino-Rodriguez et al., 2001) have been 
previously described, an erythroid/B cell bipotent progenitor has not been identified and 
warrants further investigation. 
The observation that only one recipient out of the three demonstrated donor-
derived cells in all lineages suggest that there is a multipotent progenitor within the KLS– 




In vitro assessment of the KLS– subset  
suggests a weak T cell potential 
 
 The T cell potential demonstrated by the rare MPP of KLS– MPP was not entirely 
convincing (Figure 4.4E).  Hence, an in vitro experiment was conducted to confirm the T 
cell potential.  Sorted progenitor cells from KLS MPP and CLP were also used as 
positive controls.  Sorted 100 cells per progenitor population per well was plated onto 
multiple wells seeded with OP9-DL1.  The culture media was also supplemented with IL-
7 and Flt3L to drive T cell development.  The cells were cultured for 14 days, and 
analyzed with flow cytometry.  T cell potential was determined using anti-CD44, anti-
CD25 and anti-Thy1.1 antibodies to identify cells that have committed to the T cell 
lineage by progressing to DN2 stage (CD44+ CD25+ Thy1.1+) of thymocyte 
development as previously shown (Karsunky et al., 2008).  The results showed that only 
a fraction of KLS– MPP seeded wells generated cells of T lineage, and when done so, 
they did it very poorly (Figure 4.5).  The wells seeded with KLS MPP showed a greater 
fraction of wells generating T lineage cells, and did so most robustly out of the three 
populations tested.  CLP also generated a frequent number of T lineage cells at 
intermediate level.  The results are consistent with the currently accepted model that KLS 
MPP is the progenitor population of CLP.  The weak T cell output seen in KLS– MPP 
cells confirmed our previous estimate that multipotent progenitor activity within the 
KLS– MPP fraction is rare and exhibits a limited capacity for multipotency.   
 
Discussion 
 In this report we have demonstrated that myeloid progenitors in the KLS– 
compartment include a multipotent progenitor-like population within the CD62L+Flt3+ 
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subset.  This subset is phenotypically similar to KLS MPP, with the exception of Sca-1 
level, leading us to suspect that it may be the most proximal progeny of KLS MPP.  In 
vivo results have shown that when a large number of the subset was transplanted, they 
generated a significant amount of progenies in all lineages, prompting us to name them 
KLS– MPP.  Subsequent in vivo and in vitro experiments have suggested that the 
multipotent progenitors within the KLS– MPP fraction may be rare and of limited 
capacity.   
 When a limited number of KLS– MPP were transplanted into lethally irradiated 
recipients, despite producing only transient, small quantities of platelets, myeloid 
leukocytes, and T cells, KLS– MPP generated significant amounts of RBC and B cells.  
The observed RBC and B cell levels were similar to those of the other two recipients with 
putative erythroid/B cell bipotent progenitors.  This may be explained by the possibility 
that KLS– MPP contains mostly erythroid/B cell bipotent progenitors and much fewer 
MPP, which were responsible for generating the cells of the other lineage.  It is also 
possible that multipotency observed in KLS– MPP, including the erythroid/B cell 
bipotency, may be due to individual non-multipotent precursors with already established 
lineage commitment that are contributing to the apparent multipotency in this subset.  
Therefore, future experiments examining this subset at clonal level are required to 
confirm the existence of multipotent progenitors.   
 Previous studies have reported that there are B220+ B precursors in the c-KitHigh 
Sca-1– compartment, overlapping with the myeloid progenitor population, however, this 
phenomenon occurs only in juvenile mice and not observed in adult mice as used in our 
experiments (Ogawa et al., 2000).  Since we have observed significant B cell output from 
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KLS– MPP, finding a B cell precursor that lacks B220 expression from the previously 
categorized as a pool of myeloid progenitors would be a relevant addition to the field of 
B cell development. 
 Interestingly, early T cell potential was observed around week 2 posttransplant 
event throughout the experiments (Figure 4.2E, 4.3D, 4.4E).  These early T cell events 
may indicate relatively mature bone marrow-derived progenitors that have homed to the 
thymus, instead of the bone marrow, and initiated T cell generation.  The competitive 
transplant experiment of KLS– MPP versus KLS MPP showed that KLS– MPP did 
generate a minute but detectable amount of T cells at week 2, however, did not generate 
T cells at later times (Figure 4.3D).  This may indicate the early homing of KLS– MPP to 
the thymus for T cell generation, only to be overtaken later when KLS MPP generated the 
primary wave of thymocytes.  To verify that early homing takes place, temporal kinetics 
for thymus seeding by KLS– MPP must be examined directly and compared to the 
homing kinetics by KLS MPP and HSC. 
 Also, we have not investigated the expression patterns of CD62L and Flts3 in the 
previously identified CMP, GMP and MEP populations of the KLS– fraction.  Since we 
have uncovered a potentially most immature population within the KLS– fraction through 
expressions of CD62L and Flt3, it would be interesting to see if the two markers are also 
expressed in CMP, the most immature population of the three. 
 Lastly, the evidence showing that CD62L+ Flt3+ subset of KLS– fraction exhibits 
multipotency and that CD62L–Flt3– cells have lost lymphoid lineage proposes a new 
model in which the downregulation of CD62L and Flt3 marks a maturation step from 




Mice carrying the Thy1.1 and Ly5.1 alleles on the C57BL background were 
generated in our animal facility by mating the BKa.AK-Thy1a/Ka and B6.SJL-Ptprca 
Pep3b/BoyJ strains and selecting for cosegregation of Thy1.1 and Ly5.1 (GFP–
Thy1.1+HbbS mice).  GFP transgenic mice, generated by microinjection of C57BL/6 
oocytees, were kindly provided by Dr. Masaru Okabe (Osaka University, Osaka, Japan) 
(Nakanishi et al., 2002).  In these mice, the GFP transgene is driven by the chicken β-
actin promoter and is expressed in all lineages except in the erythroid lineage.  Hence, 
hemoglobin variant alleles (HbbS and HbbD) were used to track erythroid engraftment 
(see below).  In order to generate donor mice for transplant studies, we have crossed the 
GFP transgenic mice with GFP–Thy1.1+HbbS mice to generate GFP+Thy1.1+HbbS mice.  
B6.Cg-Gpi1a HbbD H1b/DehJ mice (Harrison et al., 1988) were kindly provided by Dr. 
David Harrison (Jackson Laboratory, Bar Harbor, ME, USA).  These mice are GFP–
Thy1.1–HbbD and were used as transplant recipients.  All mice were kept in the animal 
resources center at the University of Utah under the institutional animal care and use 
committee approved protocols. 
 
Antibodies 
Monoclonal antibodies against CD2 (Rm2.2), CD3 (KT3-1.1), CD5 (53-7.3), 
CD8 (53-6.7), CD11b (M1/70), Ly-6G (RB6-8C5), TER119, B220 (CD45R; RA3-6B2), 
and CD19 (1D3) were purified from the media of cultured hybridoma cell lines. PE-
conjugated Sca-1 monoclonal antibody was purchased from PharMingen (San Diego, CA, 
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USA).  C-kit (3C11) monoclonal antibody was purified and conjugated to Alexa Fluor 
647 in our laboratory.  CD4 and CD8 monoclonal antibodies were purified and 
conjugated to allophycocyanin (APC).  Biotinylated Flt3, CD62L APC-AF750, Thy1.1 
PerCP-Cy5.5, Mac-1 PE and Gr-1 PE antibodies were purchased from eBioscience (San 
Diego, CA, USA). 
 
Isolation of hematopoietic progenitors 
 In order to remove mature cells from the harvested whole bone marrow cells, 
lineage depletion was performed.  The cells were incubated with a cocktail of rat 
antibodies to mature cell markers (CD2, CD3, CD5, CD8, CD11b, Ly-6G, TER119, 
B220 and CD19).  Secondary labeling of mature cells was performed by two successive 
incubations with magnetic beads-coupled sheep anti-rat antibodies (Dynal, Oslo, 
Norway).  Each incubation was followed by a depletion step of the labeled cells using a 
magnetic column (Dynal, Oslo, Norway).  The depleted cells were stained with various 
fluorochrome-conjugated antibodies as indicated in the figures to electronically visualize 
and sort using FACS Aria instrument (BD Immunocytometry Systems, San Jose, CA, 
USA).  DAPI was used to discriminate dead cells from live cells. 
 
Bone marrow transplantation 
 The GFP–Thy1.1–HbbD recipient mice were lethally irradiated (137Cs, 13 Gy 
delivered in a 3 hour-split dose) or sublethally irradiated (6 Gy, single dose) a day prior 
to the transplant day.  Isolated GFP+Thy1.1+HbbS donor cells were injected into the 
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recipients retro-orbitally.  The recipient mice were anesthetized with isoflurane using the 
E-Z Anesthesia system for the injection (Euthanex Corp., Palmer, PA).   
 
Peripheral blood analysis 
 For the posttransplant analysis, peripheral blood samples were collected from the 
retro-orbital sinus with heparinized capillary tubes.  The mice were anesthetized with 
isoflurane using the E-Z Anesthesia system (Euthanex Corp., Palmer, PA).  Immediately 
after the collection of blood samples, 10 ul of blood per sample were set aside for platelet 
analysis.  The rest of the samples were mixed with 500ul of 2% Dextran T500 
(Amersham Biosciences, Piscataway, NJ) in PBS and incubated at 37 degree C for 30 
min for sediment separation of the RBC and WBC fractions.  The RBC fraction was 
processed for HPLC analysis (see below).  WBC were stained with PE-conjugated 
antibodies against Mac-1 and Gr-1 for myeloid WBC detection, Biotinylated B220 or 
CD19 antibody with a subsequent labeling with Alexa Fluor 750-conjugated avidin for B 
cell detection, and CD4 and CD8 conjugated with APC for T cell detection.  Platelets and 
WBC were analyzed by FACScan flow cytometer (BD Biosciences, San Jose, CA; 
modified by Cytek Development, Fremont, CA).  Platelet analysis was performed by 
increasing forward and side scatter parameters until the platelet population could be gated 
to exclude contaminants. 
  
HPLC analysis of hemoglobin variants 
A HPLC cation exchange protocol was developed in our laboratory to 
discriminate and quantify HbbD and HbbS in the peripheral blood samples (Spangrude et 
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al., 2006).  A stock solution of 100 mM 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) 
(Sigma-Aldrich, St. Louis, MO) was prepared by dissolving 100 mg of DTNB in 2.5 ml 
of DMSO and stored at –20 degree C.  The RBC fraction was derivatized by adding 5 ul 
of the RBC fraction into 250ul of 40 mM NaCl and 2 mM DTNB and incubating at room 
temperature for 30 minutes.  Following centrifugation at 12,000 g for 2 minutes, the 
supernatant were analyzed using a VARIANT hemoglobin testing system (Bio-Rad 
Laboratories, Hercules, CA) with an optimized β–thalassemia short program. 
 
In vitro T cell potential assay 
 To assay in vitro T cell potential, OP9-DL1 co-culture system was utilized as 
previously described (Wang et al., 2005).  After the isolation of target populations using 
FACS, 100 cells per population per well was plated on 24-well plates with the stromal 
cell line OP9-DL1.  The co-cultures were supplemented with Flt3L (10 ng/ml) and IL-7 
(10 ng/ml).  The co-culture was washed intermittently to discard the old media and 
replenished with fresh media and cytokines.  After 14 days of co-culture, the cells were 
removed by forceful pipetting and analyzed for T lineage-committed cells using 
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Figure 4.1    Flow cytometric analysis of KLS– compartment.  Panel A  Whole bone 
marrow depleted of mature cells were analyzed with antibody labeling for c-kit and Sca-1.  
A typical flow cytometric representation is shown.  Separation of c-Kit+Sca-1+ (KLS) 
and c-Kit+Sca-1– (KLS–) are demonstrated.  Panel B  The cells from panel A were gated 
for the KLS– population and analyzed for Flt3 and CD62L expressions.  The cells were 
clearly present in three expression patterns: CD62L+Flt3+ (++), CD62L+Flt3– (+-), and 
CD62L–Flt3– (--).  Using FACS sorting, 100K cells from each of the three populations 
were purified and transplanted through retro-orbital injection into lethally irradiated mice 
(4 recipients for ++, 5 recipients for +-, 5 recipients for --) with 250K recipient-type 
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Figure 4.2    In vivo assessment of lineage potentials via bone marrow transplant.  
Over a 9 week period, bone marrow transplant recipients were bled with heparinized 
capillary tubes retro-orbitally to obtain peripheral blood samples.  Error bars indicate 
standard deviation.  Panel A  Platelets were identified by forward and side scatters.  
Donor-derived platelets were quantified by measuring GFP+ platelets against competitor-
derived GFP– platelets.  The percentages indicate the donor-derived platelets among total 
platelets in peripheral blood.  Panel B  Donor-derived RBC’s HbbS variant was measured 
against recipient type HbbD to quantify donor-derived RBC via HPLC.  Panel C  To 
determine myeloid potential, the amount of donor-derived leukocytes of myeloid lineage, 
granulocytes and monocytes, in the blood were measured.  The percentages indicate the 
donor-derived fraction of the total myeloid leukocytes in the blood.  Panel D  To 
determine lymphoid lineage, donor-derived B cells were identified and quantified.  The 
percentages indicate the donor-derived B cell fraction of the total B cells in the peripheral 
blood.  Panel E  The other member of the lymphoid lineage, T cells, are quantified here.  
Donor-derived T cell fraction is indicated by the percentages.   Generally, T cell presence 
in the peripheral blood is detected later than B cell presence, due to T cell’s 


































































































Figure 4.3    Competitive bone marrow transplant of Sca-1+ (KLS) MPP and Sca-1– 
(KLS–) MPP.  Panel A  A histogram schematic for peripheral blood analysis for the 
detection of the two donor-derived cells are shown.  The transplant recipient derived-cells 
that express Ly5.2 and is not detectable by anti-Ly5.1-FITC antibody labeling or GFP 
expression is represented as the dotted curve.  The Ly5.1-expressing KLS MPP-derived 
cells are represented as the gray curve.  The GFP+ KLS– MPP-derived cells are 
represented as the black curve.  Panel B  Quantification of donor-derived myeloid 
leukocytes are shown.  KLS MPP-derived granulocytes and monocytes are shown in gray.  
KLS– MPP-derived cells are shown in black.  No myeloid leukocytes from KLS– MPP 
were detected.  Panel C  Donor-derived B cells are shown as in panel B.  A minute but 
detectable amount of KLS– derived MPP was present.  Panel D  As in panel C, donor-
derived T cells are shown to assess lymphoid potential.  No significant amount of T cells 
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Figure 4.4    Double-sorted KLS– MPP output for the assessment of Meg/E, myeloid 
leukocyte and lymphoid potentials.  For the transplant, 2000 double-sorted KLS– MPP 
cells were injected into three lethally irradiated mice with 250K recipient-type competitor 
whole bone marrow cells.  The average output found among the three recipients is shown 
as the black line.  The percentages indicate the fraction of donor-derived cells from the 
total cells of the indicated lineage in the peripheral blood.  Panel A  Only a small amount 
of donor-derived platelets was detected from mouse 2.  Mouse 1 and mouse 2 did not 
show any donor-derived platelet engraftment.  Panel B  All three recipients showed an 
early burst of RBC activity.  Panel C  All three recipients showed an early production of 
myeloid leukocytes, however, only one recipient (mouse 2) showed a nominal amount of 
cells while the other two showed only trace amounts.  Panel D  Strong B cell output was 
observed in all three recipients.  Panel E  As in panel A and C, only mouse 2 showed 
some measurable amount of T cells,  Other two recipients generated barely detectable 





































































Figure 4.5    In vitro assessment of T cell potential in KLS– MPP versus KLS+ MPP 
and CLP.  In order to assay T cell potential, 100 cells per progenitor population per well 
were cultured with OP9-DL1 stromal cell line and supplemented with IL-7 and Flt3L 
cytokines to drive T cell development.  The observed T cell output has been standardized 
to the average T cell output observed from KLS MPP seeded wells.  Individual open 
symbols indicate the degree of T cell output observed per well.  The closed symbols 




























































































































































Identification of the CD62L– HSC compartment 
Since the initial FACS-mediated enrichment of HSC using the expression patterns 
of Sca-1 and Thy1.1 (Spangrude et al., 1988), an impressive array of novel markers have 
been utilized in the quest for the purification of HSC.  The current surface marker code 
for HSC enrichment is Sca-1+C-kitBRIGHTThy1.1LOWFlt3–CD150+CD48–CD244–CD34–
Rh-123–/LOWLin– (Spangurde et al., 1988; Spangrude and Johnson, 1990; Besmer, 1991; 
Ikuta and Weissman, 1992; Okada et al., 1993; Li and Johnson, 1995; Osawa et al., 1996; 
Morrison et al., 1997; Rawls et al., 2001; Yang et al., 2005; Kiel et al., 2005; 
Papathanasiou, 2009)  Despite the discovery of numerous markers for HSC enrichment, 
no group has made the claim of achieving the absolutely pure HSC population, 
suggesting that the quest for the comprehensive marker set for HSC purification is not yet 
complete. 
We have established the utilization of CD62L as an effective tool for the 
enrichment of HSC.  In vivo evidence demonstrated that the fractionation of the KLS 
population using CD62L yielded a CD62L+ MPP subset and a CD62L– HSC subset 
(Figure 2.2 and 2.3).  Our data showed that co-staining of KLS cells with CD62L and 
Thy1.1 resulted in a similar distribution of cells compared to the previously established 
stem cell markers Flt3 and Thy1.1 (Figure 2.1A and 2.1B).  As one might expect from 
this result, CD62L and Flt3 demonstrated a high frequency of co-expression, 
approximately 75% of KLS cells (Figure 3.1B).  Interestingly, transplanting 500 cells of 
the CD62L+ fraction successfully rescued lethally irradiated recipients.  In contrast, our 
laboratory has reported previously that 1000 Thy1.1LOW CD62L+ donor cells could not 
rescue lethally irradiated mice (Perry et al., 2004).  The reasons for this discrepancy are 
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not clear, but may be due to the general health of the irradiated mice in the two 
experiments, differences in cell preparative methods, or other technical issues.  We have 
also established CD62L as a highly effective tool for the segregation of HSC and MPP as 
evidenced by the transplant experiment showing a strong HSC activity with 100 CD62L– 
cells and a complete lack of HSC activity in a population containing 10,000 CD62L+ 
cells (Figure 2.4A and 2.4B). 
In addition, our results establish CD62L as an efficient tool for enriching HSC 
beyond the capability of the widely used Flt3–Thy1.1LOW strategy.  Our CD62L 
expression analysis showed that there is a significant number of CD62L+ cells within the 
Flt3–Thy1.1LOW compartment (Figure 2.5D, 2.5E and 2.6C).  Subsequent transplant 
experiments utilizing KLSF– CD62L– and KLSF– CD62L+ cells demonstrated that 
>99% of HSC activity was localized to the KLSF– CD62L– compartment, while the 
KLSF– CD62L+ compartment exhibiting only a trace amount of activity (Figure 2.6; see 
the RU calculations in Chapter 2). 
Our experiments have established CD62L as an efficient marker for HSC 
enrichment within the context of Flt3; however, the same has not been shown within the 
context of other markers.  As discussed above, there are numerous markers that have 
been shown to also be effective for HSC enrichment.  Therefore, future studies are 
warranted to investigate the co-expression profiles of CD62L with other HSC markers.  
In addition, it would be interesting to test the overall enhancement of HSC enrichment by 




Evidence for gradual and abrupt population shifts 
 One of the central debates among early hematopoietic development researchers is 
regarding the model of HSC differentiation.  Recently, the version of the hematopoietic 
tree established by the Weissman group (Morrison et al., 1997; Kondo et al., 1997; 
Akashi et al., 2000; Adolfsson et al., 2001; Christensen and Weissman, 2001) has been 
the subject of intense scrutiny.  The tree describes each early hematopoietic population as 
a stage of hematopoietic differentiation, progressing with abrupt loss of lineage potential 
and self-renewal capability.  While it is now generally accepted that the loss of lineage 
potential is gradual and not limited to a particular population of cells (Adolfsson et al., 
2005; Lai et al., 2005; Forsberg et al., 2006; Lai and Kondo, 2006), there are instances in 
which abrupt changes are evident.  For example, the progression out of the HSC 
compartment is an abrupt process that is accompanied by changes in several markers.  In 
our own studies, we have demonstrated that the expression of CD62L efficiently marks 
the end of capacity for continuous self renewal (Chapter 2).  Other markers of HSC were 
established based on similar observations.  However, this was not true for every stem cell 
marker.  When we attempted to segregate the Sca-1HIGHCD62L– and Sca-1LOWCD62L– 
fraction of the KLS population, we observed that there was a greater HSC activity in the 
Sca-1HIGH fraction, suggesting that it contained a greater number of HSC than the Sca-
1LOW fraction (Figure 2.5).  Together, our results characterize two stem cell markers that 
are expressed differentially by HSC: CD62L, expression of which indicates abrupt loss of 
the stem cell’s self-renewal capacity, and Sca-1, the expression of which is gradually lost 
by HSC as they differentiate. 
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 These observations suggest the need for a comprehensive compilation of known 
markers and their expression patterns by the cells of early hematopoietic differentiation.  
This would result in a more accurate depiction of the hematopoietic tree, avoiding 
overgeneralization and misunderstanding of the events surrounding hematopoiesis. 
 
Heterogeneity of MPP 
 The traditionally defined Flt3+ Thy1.1LOW MPP population within the KLS subset 
has been shown to contain heterogeneous progenitor populations.  Adolffson et al. have 
established lymphoid-biased multipotent progenitors (LMPP) as the top 25% of KLS 
cells for Flt3 expression that overlapped significantly with the traditional MPP but 
included limited Meg/E potential (Adolffson et al., 2005).  More convincing results came 
from Kondo’s group, which demonstrated that the MPP compartment contains two 
distinct populations according to VCAM-1 expression (Lai et al., 2005; Lai and Kondo, 
2006).  They reported that the VCAM-1– population was functionally similar to the 
LMPP, while the VCAM-1+ population contained MPP-like activity.  Interestingly, they 
also reported that the VCAM-1+ population of KLS actually contained Flt3HIGH and 
Flt3LOW populations.  This suggests that the Flt3HIGH population within the VCAM-1+ 
subset may overlap with the LMPP subset, and that the Meg/E potential of the VCAM-1+ 
subset may originate from the Flt3LOW subset.  These reports indicate the necessity for the 
utilization of multiple markers to properly identify and subfractionate progenitor 
populations. 
 Our findings showed that CD62L is also capable of subfractionating the 
traditional MPP.  We have observed that the MPP population contains CD62L+ and 
 120
CD62L– subsets with majority of cells belonging to the CD62L+ subset (Figure 3.1).  
Furthermore, our data indicated that these subpopulations can be further divided to Sca-
1HIGh  and Sca-1LOW populations.  In vivo engraftment data of the four subpopulations 
demonstrated a gradual loss of Meg/E potential as the cells of the KLS MPP 
compartment lost Sca-1 expression without a significant loss in the lymphoid potential 
(Figure 3.3 and 3.4).  In addition, the data showed that with the upregulation of CD62L, 
the progenitors developed a T cell-lineage bias (Table 3.1).  Retrospective analysis of 
Flt3 levels in the CD62L+ and CD62L– MPP fractions showed the presence of similar 
expression intensity of Flt3, indicating that Flt3 itself cannot be used to distinguish the 
CD62L+ and CD62L– populations, despite the high degree of co-expression we have 
observed previously (Figure 3.1B and 3.6).  The detection of a CD62L– fraction within 
the KLS MPP population also indicated that the CD62L-mediated HSC enrichment in 
Chapter 2 contains Flt3+ MPP contaminants and that in order to achieve higher purity, 
we must employ both markers. 
 
Discovery of a rare KLS– MPP population 
 We have traced CD62L expression into the KLS– compartment to determine if a 
primitive MPP population resembling the KLS MPP population existed.  The surface 
marker profile of CD62L and Flt3 in KLS– fraction demonstrated that there was a 
significant number of cells that expressed both markers (Figure 4.1B).  Looking at the 
surface phenotype only, these cells resembled the phenotype of the KLS MPP cells with 
the sole exception of lacking Sca-1 expression.  Therefore, the subset was referred to as 
KLS– MPP.   
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 In vivo engraftment data showed that the KLS– MPP population does contain 
MPP activity, however, it was present prominently when a large number of cells were 
transplanted (Figure 4.2).  When a limited number of cells were transplanted, the KLS– 
MPP subset exhibited MPP activity rarely (Figure 4.4).  The in vitro assay also 
demonstrated that KLS- MPP cells exhibit a minor T-lineage activity (Figure 4.5).  The 
discovery of a rare KLS– MPP subset was unexpected.  The KLS– fraction has been 
previously characterized as a myeloid compartment that contains common myeloid 
progenitors (CMP) (Akashi et al., 2000).  It is possible that the MPP activity we have 
observed represents a remnant of fading KLS MPP progenitors as they differentiate 
toward myeloid lineage commitment and downregulate Sca-1.  It is also possible that the 
observed MPP activity represents a conglomeration of progenies generated from multiple 
types of progenitors with limited lineage potentials.  A clonal analysis is required to 
verify that the multipotency observed is derived from a common progenitor rather than a 
mixture of unipotent precursor cells. 
 
Evidence for B cell/erythroid bipotent progenitor 
 During the investigation of the KLS– MPP fraction, we have discovered evidence 
for a B cell/erythroid bipotent progenitor.  Our transplant experiment, using a limited 
number of donor KLS– MPP cells, generated either MPP-like activity or small but 
detectable numbers of B cells and RBC (Figure 4.4).  The competitive transplant study 
also revealed that these cells generated B cells, but not myeloid WBC, indicating that the 
progenitors responsible for B cell output were not CMP (Figure 4.3). 
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While the capacity of the CMP to produce B cells (Yang et al., 2005; Yang et al., 
2007) and the B cell progenitors’s capacity for macrophage production (Montecino-
Rodriguez et al., 2001) have been previously described, a B cell/erythroid bipotent 
progenitor has not been identified.  It is possible that the previously described CMP’s 
capacity for B cell development may have been the result of B cell/erythroid bipotent 
progenitors present within the CMP compartment.  Again, these issues points to the need 
for the development of a clonal analysis that is sensitive enough to detect progenitors 
with limited potential to determine in vivo the source of progenies of unknown origin. 
 
Denouement 
 In conclusion, this dissertation presents the evidence gathered to test the 
hypothesis that CD62L can be used as a marker of hematopoietic differentiation.  As the 
origin of hematopoiesis, HSC represents the foremost primitive population.  Our 
demonstration that CD62L is not expressed by HSC establishes CD62L as a marker of 
HSC enrichment and the expression of CD62L as a marker of hematopoietic 
differentiation.   
The MPP subpopulation with a severely reduced Meg/E potential represents the 
end stage within the KLS compartment.  Our data support the CD62L hypothesis by 
showing that the majority of MPP in the hematopoietic stem cell compartment expresses 
CD62L, and that the CD62L+ MPP population exhibited minimal Meg/E potential.  Our 
data also identified a CD62L– Flt3+ population that behaved as a traditionally described 
MPP and therefore, represents a transitional stage population between the CD62L+Flt3+ 
MPP and HSC.   
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Our experiments demonstrated a general trend that as Sca-1 level decreases, the 
progenitors progress further in their state of maturation.  Our data showed that as Sca-1 
level decreased in the CD62L– HSC compartment, the frequency of HSC also decreased.  
We also observed that as the Sca-1 level drops within the MPP population, so does the 
overall number of progenies produced.  Lastly, as Sca-1 expression reached an 
undetectable level in the KLS– fraction, only a rare MPP activity and severely lineage 
limited progenitor activity were observed. 
These findings suggest the need for the visualization of flow cytometric 
multiparameter analysis.  With a typical dot plot representing only two parameters 
simultaneously, a biologically significant change in the expression of other parameters 
may go unnoticed to more casual observers.  For instance, we have observed that the 
changes in CD62L and Sca-1 expressions in early hematopoietic progenitors resulted in 
the loss or reduction of progenitor activity.   However, we have not examined their co-
expression relationship in the context of another marker.  We were able to take glimpses 
of their expression relationship as we attempted to subfractionate progenitor populations 
using three markers, such as in Chapter 2 where we utilized Flt3, CD62L and Sca-1 to 
obtain KLSF– CD62L–, KLSF– CD62L+, KLF–CD62L–Sca-1HIGH and Sca-1LOW ; 
however, a comprehensive examination of their expression patterns has not been 
performed.  Therefore, as an example, a semi-three-parameter model using three stem 
cell markers have been constructed to demonstrate the benefits of examining the 
relationships of three parameters simultaneously (Figure 5.1). 
The three-parameter model was constructed using typical two-parameter dot plots 
of CD62L versus Thy1.1 at three separate levels of Sca-1 expression (Sca-1LOW, Sca-1INT 
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and Sca-1HIGH).  Thy1.1 is represented on the X-axis, CD62L on the Y-axis, and Sca-1 on 
the Z-axis.  The upper left quadrant of each Z-plane indicates the Thy1.1–CD62L+ cells 
of KLS.  The change in the expression profile of CD62L versus Thy1.1 as Sca-1 level 
decreases is conspicuously evident.  The increase in the number of cells present in the 
putatively most mature compartment of KLS is dramatic as Sca-1 level progresses from 
high to intermediate to low, while the number of cells in the immature CD62L–Thy1.1+ 
compartment decreases.  By studying this model and recognizing the change in the 
CD62L expression pattern in the context of the other two already known stem cell 
markers, one may suspect that CD62L may mark different stages in hematopoietic 
differentiation without examining experiment results.  An alternative data presentation 
such as the 3-parameter model provides additional details, and is helpful in enhancing the 
understanding and interpretation of data.  Therefore, as we expand the number of markers 
available for studying early hematopoietic events, it is practical to utilize other methods 
such as 3D analysis that may be more appropriate for the execution of experiments and 
analysis of data to facilitate the progress of research.  
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